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Introduction
Reports of tuberculosis (TB) cases are submitted to the Division of TB Elimination (DTBE), 
Centers for Disease Control and Prevention (CDC), by 60 reporting areas (the 50 states, the 
District of Columbia, New York City, Puerto Rico, and other jurisdictions in the Pacific and 
Caribbean). In January 1993, DTBE, in conjunction with state and local health departments, 
implemented an expanded TB surveillance system. The expanded system collects additional 
information for each reported TB case in order to better monitor trends in TB, including drug- 
resistant TB, in the United States. A software package (SURVS -TB) for data entry, analysis, 
and transmission of case reports to CDC was designed and implemented as part of the expanded 
TB surveillance system. In 1998, the Tuberculosis Information Management System (TIMS) 
replaced SURVS-TB in order to provide reporting areas with a comprehensive software for 
surveillance, patient management, and program evaluation.
This publication, Reported Tuberculosis in the United States, 1998, presents summary data 
for TB cases reported to DTBE during 1998. It is similar to previous publications (page 5, #19) 
and contains five major sections. First, overall TB case counts and case rates with selected 
demographic characteristics are presented for the 50 states, New York City, and the District of 
Columbia. Second, TB case counts and case rates are presented by state with tables of selected 
demographic and clinical characteristics. In the third section, data collected as part of the 
expanded system (e.g., initial drug resistance, HIV status) are presented by reporting area. The 
fourth section provides TB case counts and case rates by metropolitan statistical areas (MSAs: 
see Technical Notes for further details) with tables of selected demographic and clinical 
characteristics. Finally, the fifth section is a collection of figures, including some data not 
presented in tabular format.
This is the second year several new tables (Tables 10,11,26) and figures (Figures 8, 9,11) 
have been incorporated. Tables 10 and 11 present the country of origin and the duration of 
residence in the United States by state, for cases among foreign-bom persons. Figures 8 and 9 
present the number and percentage of the overall national total, by year, for cases among 
U.S.-bom and foreign-bom persons, respectively. Table 26 is the most recent addition to the 
section presenting data collected as part of the expanded system. This table provides estimates of 
completion of TB therapy (COT) rates by reporting area (see Technical Notes for further details). 
Figure 11 presents a U.S. map showing isoniazid resistance among cases without a-history of 
previous TB. In addition, for the second year, Tables 12,13, and 29 include all miliary cases 
under the classification of both pulmonary and extrapulmonary disease rather than the 
classification of extrapulmonary as was done in annual summaries prior to 1997.
To help interpret the data, an Executive Commentary (page 2) and Technical Notes (page 71) 
have been included. In addition, the current case definition {MMWR 1997;46 [No. RR-10]:40-1) 
and “Recommendations for Counting Reported Tuberculosis Cases” are provided in the 
Appendix. The recommendations for counting TB cases, which update the January 1977 
recommendations, were first published in Reported Tuberculosis in the United States, 1996.
We will continue to adapt and improve this publication to better monitor trends in TB in the 
United States. Your comments and suggestions that may assist us in this process will be greatly 
appreciated.
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Executive Commentary
During 1998, a total of 18,361 TB cases (6.8 cases per 100,000 population) were reported to 
CDC from the 50 states and the District of Columbia, representing a 7.5% decrease from 1997 
and a 31% decrease from 1992, when the number of cases peaked during the resurgence of TB in 
the United States. The national TB case rate also steadily decreased during this period (Table 1). 
In 1998,6% of cases were reported in children under 15 years old, 8% in persons aged 15-24 
years, 35% in persons aged 25-44 years, 27% in persons aged 45-64 years, and 24% in persons 
aged 65 years and older (Table 2). During 1992-1998, there was a decline in both the number of 
cases reported in each of these age groups and the respective TB case rates.
An important consideration is that the overall national trends reflect the impact of varying 
changes within population subgroups. For example, the overall decrease in TB cases during 
1992-1998 primarily reflected a 44% decrease in the number of cases among U.S.-born persons, 
with substantial declines in all age groups. In contrast, the total number of cases among 
foreign-bom persons increased 4% during this period, reflecting a small increase among adults 
aged 25-44 years, a larger increase among adults aged ^45 years, and a substantial decline among 
children aged <15 years. In terms of case rates, there was a 46% decrease in the case rate among 
U.S.-bom persons (from 8.2 to 4.4 per 100,000), and there was an 18% decrease in the case rate 
among foreign-bom persons (from 34 to 28 per 100,000).
The overall trends also reflect the impact of changes by geographic location. For example, 
during 1992-1998, the seven states (California, Florida, Georgia, Illinois, New Jersey, New York, 
and Texas) reporting the highest number of cases (60% of the total number of U.S. cases in 1998) 
experienced a substantial decrease in both the annual number of reported cases and case rate. 
Overall substantial decreases also occurred in 14 other states during the 7 year period. In the 
remaining 23 states and the District of Columbia, annual case counts fluctuated (e.g. an increase 
followed by a decrease) or remained relatively stable during 1992-1998. Most of these states had 
case rates below 3.5 per 100,000 (17 states) or reported less than 100 cases (16 states) in 1998.
The resurgence of TB in the United States in the late 1980s and early 1990s was associated 
with the emergence of multidrug-resistant TB (MDR TB) and the HIV/AIDS epidemic.1,2 
Analysis of initial drug susceptibility test results for isolates from persons with culture-positive 
TB found a relatively stable level of resistance to at least isoniazid and a decreasing level of MDR 
TB during 1993-1997.3,4 Data from cases reported during 1998 confirm these trends, with 8% of 
isolates resistant to at least isoniazid and 1.1% resistant to at least isoniazid and rifampin (MDR 
TB) (Table 21). The decrease in the level of MDR TB was influenced by a substantial decrease in 
New York City; however, during 1993-1998, the proportion of MDR TB cases reported from U.S. 
areas excluding New York City decreased from 1.7% to 0.9%.
Incomplete reporting has limited the analysis of national TB surveillance data by HIV status. 
Reporting of HIV status has improved slowly since 1993, the year such information was first 
included on TB case reports submitted to CDC. In 1998, 55% of TB case reports for persons aged 
25-44 years included information about HIV status. Twenty-one states and New York City 
reported this information for at least 75% of cases among persons in this age group (Table 22).
To help estimate the proportion of reported TB cases with HIV coinfection, state health 
departments have compared TB and AIDS registries.5 Using registry match data to supplement 
reported HIV test results on the individual TB case report, minimum estimates of the proportion 
with HIV coinfection range from 15% in 1993-1994 to 10% in 1997 for persons of all ages 
reported with TB and from 29% in 1993-1994 to 21% in 1997 for persons aged 25 to 44 (CDC,
2
unpublished data). The impact of the HIV/AIDS epidemic also differs by geographic location.
For example, in 1998, over 35% of TB cases in persons aged 25-44 years reported from Delaware, 
Florida, and New York City were coinfected with HIV, whereas (among states with more than 5 
cases in this age group), <10% of cases from Ohio, South Carolina, and Wisconsin were reported 
with HIV coinfection.
During 1992-1998, the declines in the overall number of reported TB cases and in the level of 
MDR TB appear to reflect successful efforts to strengthen TB control following the resurgence of 
TB and the emergence of MDR TB. Emphasizing the first priority of TB control6 (i.e., promptly 
identifying persons with TB, initiating appropriate therapy, and ensuring completion of therapy) 
has likely been the most important factor in achieving this improvement, through the reduction of 
community transmission of M. tuberculosis, particularly in areas with a high incidence of AIDS.7 
Improvements in infection control practices in nosocomial and other congregate settings, 
declining AIDS incidence, and the decreasing number of MDR TB cases also appear to have 
contributed to the overall decrease; however, the contribution of these factors has been difficult to 
measure. The substantial decline in both the number of reported cases among U.S.-born persons 
and the case rate for U.S.-born persons supports these inferences. In comparison, the relatively 
stable number of reported cases among foreign-bom persons along with the modest decline in the 
case rate among foreign-bom persons is consistent with other analyses of TB surveillance data 
that indicate that most cases of TB among foreign-bom persons residing in the United States 
result from infection with M. tuberculosis in the person’s country of birth.8 As the percentage of 
reported TB cases among foreign-bom persons continues to increase, the elimination of TB in the 
United States will depend increasingly on the elimination of TB among foreign-bom persons.9 
CDC, in collaboration with state and local health departments, recently published 
recommendations for enhancing TB control efforts in the foreign-bom,9 and is currently working 
with these jurisdictions to expand efforts based on these recommendations.
To move from TB control to TB elimination in the United States, the Advisory Council for 
the Elimination of Tuberculosis has emphasized that existing efforts must be sustained and 
enhanced.10 Monitoring the success of these efforts depends on continued surveillance at the 
national, state, and local levels. The expanded national TB surveillance system has proven its 
usefulness in assisting with this important activity, particularly through the collection of data on 
initial drug susceptibility results. Further assessment includes another important benchmark of 
TB program success: the rate of completion of therapy. Future evaluation of trends in completion 
of therapy, based on analysis of data collected through national surveillance (Table 26), will also 
assist in measuring continued progress.
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Table 1. Tuberculosis Cases and Case Rates per 100,000 Population, Deaths and Death Rates
per 100,000 Population: United States, 1953-1998
Tuberculosis Cases Tuberculosis Deaths
Year Number flate(a)
Percent Change
Number Rate(a)
Percent Change
Number Rate Number Rate
1953 84,304 53.0 -  - .  _ 19,707 12.4 _ . . .
1954 79,775 49.3 -5.4 -7.0 16,527 10.2 -16.1 -17.7
1955 77,368 46.9 -3.0 -4.9 15,016 9.1 -9.1 -10.8
1956 69,895 41.6 -9.7 -11.0 14,137 8.4 -5 .9 -7.7
1957 67,149 39.2 -3.9 -5.8 13,390 7.8 -5 .3 -7.1
1958 63,534 36.5 -5.4 -6.9 12,417 7.1 -7 .3 -9 .0
1959 57,535 32.5 -9.4 -11.0 11,474 6.5 -7 .6 -8.5
1960 55,494 30.8 -3.5 -5.2 10,866 6.0 -5 .3 -7 .7
1961 53,726 29.4 -3.2 -4.5 '  9,938 5.4 -8 .5 -10.0
1962 53,315 28.7 -0.8 -2 .4 9,506 5.1 -4 .3 -5 .6
1963 54,042 28.7 +1.4 0.0 9,311 4.9 -2.1 -3 .9
1964 50,874 26.6 -5.9 -7 .3 8,303 4.3 -10.8 -12.2
1965 49,016 25.3 -3.7 -4.9 7,934 4.1 -4.4 -4 .7
1966 47,767 24.4 -2.5 -3 .6 7,625 3.9 -3.9 -4 .9
1967 45,647 23.1 -4.4 -5 .3 6,901 3.5 -9.5 -10.3
1968 42,623 21.3 -6.6 -7 .8 6,292 3.1 -8.8 -11.4
1969 39,120 19.4 -8.2 -8 .9 5,567 2.8 -11.5 -9 .7
1970 37,137 18.3 -5.1 -5 .7 5,217 2.6 -6 .3 -7.1
1971 35,217 17.1 -5.2 -6.6 4,501 2.2 -13.7 -15.4
1972 32,882 15.8 -6.6 -7 .6 4,376 2.1 -2 .8 -4.5
1973 30,998 14.8 -5.7 -6.3 3,875 1.8 -11.4 -14.5
1974 30,122 14.2 -2.8 -4.1 3,513 1.7 -9 .3 -5.6
1975 33,989 15.9 - - 3,333 1.6 -5.1 -5 .9
1976 32,105 15.0 -5.5 -5 .7 3,130 1.5 -6.1 -6 .3
1977 30,145 13.9 -6.1 -7.3 2,968 1.4 -5.2 -6 .7
1978 28,521 13.1 -5.4 -5.8 2,914 1.3 -1 .8 -7.1
1979 27,669 12.6 -3.0 -3.8 2.007(b) 0.9(b) -31.1(b) -30.8(b)
1980 27,749 12.3 +0.3 -2.4 1,978 0.9 -1 .4 0.0
1981 27,373 11.9 -1.4 -3.3 1,937 0.8 -2.1 -11.1
1982 25,520 11.0 -6.8 -7.6 1,807 0.8 -6 .7 0.0
1983 23,846 10.2 -6.6 -7.3 1,779 0.8 -1 .5 0.0
1984 22,255 9.4 -6.7 -7.8 1,729 0.7 -2 .8 -12.5
1985 22,201 9.3 -0.2 - 1.1 1,752 0.7 + 1.3 0.0
1986 22,768 9.4 +2.6 + 1.1 1,782 0.7 + 1.7 0.0
1987 22,517 9.3 -1.1 - 1.1 1,755 0.7 - 1.5 0.0
1988 22,436 9.1 -0.4 -2.2 1,921 0.8 + 9.5 +14.3
1989 23,495 9.5 +4.7 + 4.4 1,970 0.8 + 2.6 0.0
1990 25,701 10.3 +9.4 + 8.4 1,810 0.7 -8.1 -12.5
1991 26,283 10.4 +2.3 + 1.0 1,713 0.7 -5 .4 0.0
1992 26,673 10.5 +1.5 + 1.0 1,705 0.7 -0.5 0.0
1993 25,287 9.8 -5.2 -6 .7 1,631 0.6 -4 .3 -14.3
1994 24,361 9.4 -3.7 -4.1 1,478 0.6 -9 .4 0.0
1995 22,860 8.7 -6.2 -7 .4 1,336 0.5 -9 .6 -16.7
1996 21,337 8.0 -6.7 -8 .0 1,202 0.5 -10.0 0.0
1997 19,851 7.4 -7.0 -7.5 1,166 0.4 -3.0 -20.0
1998 18,361 6.8 -7.5 -8.1
{a)Per 100,000 population.
(b)The large decrease in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) 
and pleurisy w ith effusion (without mention of cause) are no longer included in tuberculosis deaths.
Ellipses indicate data not available.
Note: Case data after 1974 are not comparable to prior years due to changes in surveillance case definitions 
which became effective in 1975.
Table 2. Tuberculosis Cases by Race/Ethnicity, Sex, and Age: United States, 1998
Race/Ethnicity 
and Sex All Ages
Age Group Not
StatedUnder 5 5 -1 4 — 2 5 -4 4 4 5 -6 4 65+
Total Cases 18,361 841 441 1,548 6,365 4,973 4,393 0
White, Not Hispanic 4,495 92 46 139 1,024 1,276 1,918 0
Male 2,964 48 27 75 696 948 1,170 0
Female 1,530 44 19 64 328 328 747 0
Unknown 1 0 0 0 0 0 1 0
Black, Not Hispanic 5,831 206 170 397 2,309 1,716 1,033 0
Male 3,633 91 79 134 1,425 1,267 587 0
Female 2,196 115 89 213 884 449 446 0
Unknown 2 0 2 0 0 0 0 0
Hispanic(a) 4,099 262 156 592 1,612 911 566 0
Male 2,610 141 65 369 1,078 632 325 0
Female 1,463 121 91 223 530 278 240 0
Unknown 6 0 0 0 4 1 1 0
American Indian/Alaskan Native 253 11 4 11 73 94 60 0
Male 150 7 1 6 51 58 27 0
Female 102 4 3 5 22 36 32 0
Unknown 1 0 0 0 0 0 1 0
Asian/Pacific Islander 3,623 69 63 405 1,320 957 809 0
Male 2,029 37 35 187 688 593 489 0
Female 1,591 32 28 218 631 364 318 0
Unknown 3 0 0 0 1 0 2 0
Not Slated 60 1 2 4 27 19 7 0
Male 27 0 0 1 15 11 0 0
Female 33 1 2 3 12 8 7 0
Unknown 0 0 0 0 0 0 0 0
{a(Persons of Hispanic origin may be of any race.
Table 3. Tuberculosis Case Rates per 100,000 Population by Race/Ethnicity, Sex, and Age: 
United States, 1998
Race/Ethnicity 
and Sex
Age Group
All Ages Under 5 15-24-— 25 - 4 4 4 5 - 6 4 55+
Total Cases 6.8 3.4 1.1 4.2 7.6 6.7 12.8
White, Not Hispanic 2.3 0.8 0.2 0.6 1.7 2.8 6.6
Male 3.1 0.8 0.2 0.6 2.4 4.3 9.7
Female 1.5 0.8 0.2 0.5 1.1 1.4 4.4
Black, Not Hispanic 17.8 7.8 2.9 7.4 22.4 29.8 37.4
Male 23.5 6.8 2.7 6.8 29.4 49.4 54.3
Female 12.7 8.8 3.1 7.9 16.1 14.0 26.5
Hispanic(a) 13.6 7.7 2.7 11.2 16.6 21.0 32.1
Male 17.1 8.1 2.2 13.4 21.6 30.4 43.9
Female 9.9 7.3 3.2 8.8 11.2 12.3 23.5
American Indian/Alaskan Native 12.6 6.7 1.0 3.2 12.0 27,2 42.0
Male 15.3 8.5 0.5 3.4 16.8 35.4 45.0
Female 10.0 4.9 1.6 2.9 7.2 19.9 38.6
Asian/Pacific Islander 36.6 8.4 4.1 23.0 38.5 49.5 109.6
Male 42.8 8.9 4.5 25.8 42.7 66.0 156.7
Female 30.9 7.9 3.8 30.1 34.7 35.3 75.2
(a)Persons of Hispanic origin may be of any race. 
Note: See Technical Notes for source of population.
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Table 4. Tuberculosis Cases In U.S.-born Persons by Race/Ethnicity, Sex, and Age: United States 
1998
Race/Ethnicity 
and Sex
Age Group Not
StatedAll Ages Under 5 5 - 1 4 15 -24 25 -44 4 5 - 6 4 65+
Total Cases 10,675 544 278 480 3,215 3,160 2,998 0
White, Not Hispanic 3,918 77 28 92 848 1,144 1,729 0
Male 2,626 41 17 50 583 861 1,074 0
Female 1,291 36 11 42 265 283 654 0
Unknown 1 0 0 0 0 0 1 0
Black, Not Hispanic 4,973 198 139 227 1,665 1,570 974 0
Male 3,146 68 63 107 1,161 1,172 557 0
Female 1,825 110 76 120 704 398 417 0
Unknown 0 0 0 0 0 0 0 0
Hispanic(a) 1,293 214 84 119 379 308 189 0
Male 793 115 35 61 247 226 109 0
Female 497 99 49 58 130 82 79 0
Unknown 3 0 0 0 2 0 1 0
American Indian/Alaskan Native 246 11 4 10 69 92 60 0
Male 146 7 1 5 50 56 27 0
Female 99 4 3 5 19 36 32 0
Unknown 1 0 0 0 0 0 1 0
Asian/Pacific Islander 215 44 22 30 43 34 42 0
Male 127 25 13 18 21 20 30 0
Female 88 19 9 12 22 14 12 0
Unknown 0 0 0 0 0 0 0 0
Not Stated 30 0 1 2 11 12 4 0
Male 15 0 0 1 7 7 0 0
Female 15 0 1 1 4 5 4 0
Unknown 0 0 0 0 0 0 0 0
(a)Persons of Hispanic origin may be of any race.
Table 5. Tuberculosis Cases in Foreign-born Persons(a) by Race/Ethnicity, Sex, and Age: 
United States, 1998
Race/Ethnicity 
and Sex
Age Group Not
StatedAll Ages Under 5 5 - 1 4 15 -24 25 -44 45 - 6 4 55+~
Total Cases 7,591 92 161 1,063 3,121 1,788 1,366 0
White, Not Hispanic 560 14 18 47 172 127 182 0
Male 327 6 10 25 109 83 94 0
Female 233 8 8 22 63 44 88 0
Unknown 0 0 0 0 0 0 0 0
Black, Not Hispanic 842 8 31 170 440 141 52 0
Mate 474 3 16 77 261 91 26 0
Female 366 5 13 93 179 50 26 0
Unknown 2 0 2 0 0 0 0 0
Hispanic(b) 2,774 45 71 471 1,222 595 370 0
Male 1,797 24 30 307 826 398 212 0
Female 974 21 41 164 394 196 158 0
Unknown 3 0 0 0 2 1 0 0
American Indian/Alaskan Native 7 0 0 1 4 2 0 0
Male 4 0 0 1 1 2 0 0
Female 3 0 0 0 3 0 0 0
Unknown 0 0 0 0 0 0 0 0
Asian/Pacific Islander 3,393 25 40 373 1,273 920 762 0
Male 1,894 12 22 168 666 571 455 0
Female 1,496 13 18 205 606 349 305 0
Unknown 3 0 0 0 1 0 2 0
Not Stated 15 0 1 1 10 3 0 0
Male 5 0 0 0 4 1 0 0
Female 10 0 1 1 6 2 0 0
Unknown 0 0 0 0 0 0 0 0
(a) Persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, 
U.S. Minor Outlying Islands, U.S. Miscellaneous Islands, and the U.S. Virgin Islands.
(b) Persons of Hispanic origin may be of any race.
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Table 6. Tuberculosis Cases and Case Rates per 100,000 Population: States, 1908 and 1997
State
Cases Case Rates
Rank According 
to Rate
Population 
Estimates 
July 1,1998T55S" 7557 1998 — m r ---------w
United States 18,361 19,851 6.8 7.4 - - 270,299,000
Alabama 381 405 8.8 9.4 6 7 4,352,000
Alaska 55 78 9.0 12.8 5 2 614,000
Arizona 254 296 5.4 6.5 21 18 4,669,000
Arkansas 171 200 6.7 7.9 16 15 2,538,000
California 3,852 4,056 11.8 12.6 2 3 32,667,000
Colorado 79 94 2.0 2.4 42 41 3,971,000
Connecticut 128 128 3.9 3.9 30 30 3,274,000
Delaware 36 39 4.8 5.3 23 22 744,000
District of Columbia(a) 107 110 20.5 20.8 - - 523,000
Florida 1,302 1,400 8.7 9.6 7 6 14,916,000
Georgia 631 696 8.3 9.3 9 9 7,642,000
Hawaii 181 167 15.2 14.1 1 1 1,193,000
Idaho 14 15 1.1 1.2 47 48 1,229,000
Illinois 850 974 7.1 8.2 15 14 12,045,000
Indiana 188 168 3.2 2.9 34 36 5,899,000
Iowa 55 74 1.9 2.6 43 37 2,862,000
Kansas 56 78 2.1 3.0 39 34 2,629,000
Kentucky 179 198 4.5 5.1 27 24 3,936,000
Louisiana 380 406 8.7 9.3 8 8 4,369,000
Maine 13 21 1.0 1.7 48 45 1,244,000
Maryland 324 340 6.3 6.7 19 17 5,135,000
Massachusetts 282 268 4.6 4.4 26 28 6,147,000
Michigan 385 374 3.9 3.8 28 32 9,817,000
Minnesota 161 161 3.4 3.4 32 33 4,725,000
Mississippi 225 245 8.2 9.0 10 10 2,752,000
Missour 184 248 3.4 4.6 33 26 5,439,000
Montana 20 18 2.3 2.0 38 42 880,000
Nebraska 31 22 1.9 1.3 44 47 1,663,000
Nevada 128 112 7.3 6.7 14 16 1,747,000
New Hampshire 14 17 1.2 1.4 46 46 1,185,000
New Jersey 640 718 7.9 8.9 12 11 8,115,000
New Mexico 68 71 3.9 4.1 29 29 1,737,000
New York 2,000 2,265 11.0 12.5 3 4 18,175,000
North Carolina 498 463 6.6 6.2 17 20 7,546,000
North Dakota 10 12 1.6 1.9 45 43 638,000
Ohio 230 286 2.1 2.6 41 39 11,209,000
Oklahoma 198 212 5.9 6.4 20 19 3,347,000
Oregon 156 161 4.8 5.0 24 25 3,282,000
Pennsylvania 446 528 3.7 4.4 31 27 12,001,000
Rhode Island 63 38 6.4 3.9 18 31 988,000
South Carolina 286 328 7.5 8.7 13 12 3,836,000
South Dakota 23 19 3.1 2.6 35 38 738,000
Tennessee 439 467 8.1 8.7 11 13 5,431,000
Texas 1,820 1,992 9.2 10.2 4 5 19,760,000
Utah 52 36 2.5 1.7 36 44 2,100,000
Vermont 5 6 0.8 1.0 49 49 591,000
Virginia 339 350 5.0 5.2 22 23 6,791,000
Washington 265 305 4.7 5.4 25 21 5,689,000
West Virginia 42 54 2.3 3.0 37 35 1,811,000
Wisconsin 109 130 2.1 2.5 40 40 5,224,000
Wyoming 4 2 0.8 0.4 50 50 481,000
American Samoa(a.b) 5 8.3 — 62,093
Fed. States of Micronesia(a,b) — 129,658
Guam(a,b) 89 59.7 — 149,101
N. Mariana !$lands(a,b) 88 138.0 — 66,611
Puerto Rico(a,b) 201 257 5.2 6.7 - 3,860,091
Republic of Palau(a,b) 16 92.9 - 18,110
U.S. Virgin lslands(a,b) " 118,382
(a) Not ranked with the states.
(b) Not included in totals.
Ellipses indicate data not available.
Note: See Technical Notes for source of population.
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Table 7. Tuberculosis Cases by Age Group: States, 1998
Total Unknown or
State Cases Under 5 5 - 1 4 15 -24 2 5 - 44 4 5 - 6 4 65+ Missing
United States 18,361 641 441 1,548 6,365 4,973 4,393 0
Alabama 381 7 11 17 107 112 127 0
Alaska 55 4 1 4 26 14 6 0
Arizona £54 11 13 21 69 72 68 0
Arkansas 171 7 7 4 32 37 84 0
California 3,852 160 92 358 1,275 1,063 904 0
Colorado 79 4 3 3 26 15 28 0
Connecticut 128 2 2 9 50 39 26 0
Delaware 36 1 0 3 13 13 6 0
District of Columbia 107 1 1 7 48 37 13 0
Florida 1,302 28 15 76 544 392 247 0
Georgia 631 33 22 45 228 179 124 0
Hawaii 181 4 1 15 46 52 63 0
Idaho 14 0 0 1 6 4 3 0
Illinois 850 39 26 69 319 234 163 0
Indiana 188 9 8 13 48 57 53 0
Iowa 55 2 0 7 15 18 13 0
Kansas 56 4 0 5 17 12 18 0
Kentucky 179 6 1 8 38 42 84 0
Louisiana 380 14 6 23 132 114 91 0
Maine 13 0 0 0 3 4 6 0
Maryland 324 16 5 39 112 78 74 0
Massachusetts 282 7 6 30 108 77 54 0
Michigan 385 17 10 24 123 115 96 0
Minnesota 161 3 6 33 60 32 27 0
Mississippi 225 10 10 7 55 68 75 0
Missouri 184 7 1 6 53 55 62 0
Montana 20 0 0 0 4 9 7 0
Nebraska 31 0 0 0 12 10 9 0
Nevada 128 6 3 11 48 41 19 0
New Hampshire 14 0 0 2 2 3 7 0
New Jersey 640 24 18 50 260 162 126 0
New Mexico 68 4 0 4 14 17 29 0
New York 2,000 44 43 213 802 515 383 0
North Carolina 498 15 6 38 152 128 159 0
North Dakota 10 1 2 0 2 3 2 0
Ohio 230 3 6 17 62 47 95 0
Oklahoma 198 3 14 16 53 58 54 0
Oregon 156 3 4 17 71 32 29 0
Pennsylvania 448 16 10 26 137 122 137 0
Rhode Island 63 6 7 5 16 16 13 0
South Carolina 286 8 5 23 78 83 89 0
South Dakota 23 0 1 0 4 12 6 0
T ennessee 439 15 3 34 120 92 175 0
Texas 1,820 74 61 189 698 493 305 0
Utah 52 0 2 2 24 12 12 0
Vermont 5 0 0 0 1 3 1 0
Virginia 339 9 2 34 121 63 110 0
Washington 265 13 6 28 89 71 58 0
West Virginia 42 0 0 1 8 13 20 0
Wisconsin 109 1 1 11 32 31 33 0
Wyoming 4 0 0 0 2 2 0 0
American Samoa{a)
Fed. States of Micronesia(a)
Guam(a) 89 1 1 13 20 34 20 0
N. Mariana Islands(a)
Puerto Rico(a) 201 7 2 12 72 64 43 1
Republic of Palau(a) 
U.S. Virgin Islands(a)
(a)Not included in totals.
Ellipses indicate data not available.
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Table 8. Tuberculosis Cases by Race/Ethnicity: States, 1998
State
Total
Cases
White
Not Hispanic
Black
Not Hispanic Hispanic(a)
American Indian 
or
Alaskan Native
Asian
or
Pacific Islander
Unknown
or
Missing
United States 18,361 4,495 5,831 4,099 253 3,623 60
Alabama 381 144 214 7 0 16 0
Alaska 55 12 2 2 28 11 0
Arizona 254 78 17 105 39 15 0
Arkansas 171 102 44 14 0 7 4
California 3,852 519 383 1,402 24 1,522 2
Colorado 79 17 11 32 0 19 0
Connecticut 128 35 46 24 0 23 0
Delaware 36 11 11 8 0 6 0
District of Columbia 107 6 80 9 1 8 3
Florida 1,302 395 642 200 3 57 5
Georgia 631 137 385 64 3 41 1
Hawaii 181 5 0 2 0 172 2
Idaho 14 7 0 4 2 1 0
Illinois 850 183 388 132 2 143 2
Indiana 188 90 56 24 0 14 4
Iowa 55 29 8 4 0 14 0
Kansas 56 16 7 16 0 17 0
Kentucky 179 141 23 7 0 6 2
Louisiana 380 110 233 12 0 24 1
Maine 13 11 1 0 0 1 0
Maryland 324 62 163 25 0 74 0
Massachusetts 282 81 75 33 0 92 1
Michigan 385 123 180 25 1 54 2
Minnesota 131 26 66 7 10 51 1
Mississippi 225 80 130 4 0 10 1
Missouri 184 74 75 14 0 19 2
Montana 20 6 0 1 13 0 0
Nebraska 31 11 2 7 3 8 0
Nevada 128 31 18 46 0 33 0
New Hampshire *4 11 1 0 0 2 0
New Jersey 640 141 197 147 0 155 0
New Mexico 68 10 3 26 25 4 0
New York 2,000 308 754 540 1 397 0
North Carolina 498 132 287 52 3 24 0
North Dakota 10 3 0 0 5 2 0
Ohio 230 105 85 10 0 29 1
Oklahoma 198 106 18 20 41 13 0
Oregon 156 66 12 25 4 49 0
Pennsylvania 448 180 168 41 0 58 1
Rhode Island 63 19 8 19 0 17 0
South Carolina 286 51 210 10 1 14 0
South Dakota 23 4 1 0 17 1 0
Tennessee 439 222 188 7 0 22 0
Texas 1,820 336 443 865 4 153 19
Utah 52 15 3 10 6 17 1
Vermont 5 2 1 1 0 1 0
Virginia 339 82 129 40 0 84 4
Washington 265 84 27 39 14 100 1
West Virginia 42 34 6 2 0 0 0
Wisconsin 109 40 30 13 3 23 0
Wyoming 4 2 0 2 0 0 0
American Samoa(b)
Fed. States of Micronesia(b)
Guam(b) 39 i 0 b o 85 3
N. Mariana Islands(b)
Puerto Rico(b) 20i o b 199 o 2 o
Republic of Palau(b) 
U.S. Virgin Islands(b)
(a) Persons of Hispanic origin may be of any race.
(b) Not included in totals.
Ellipses indicate data not available.
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Table 9. Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons: States, 1998
State
Total
Cases
U.S.-born Persons Foreign-bom Persons(a) Unknown
------ N o % No. ---------%-------- ------ %
United States 18,351 10,675 58.1 7,591 41.3 95 0.5
Alabama 381 357 93.7 22 5.8 2 0.5
Alaska 55 43 78.2 12 21.8 0 0.0
Arizona 254 155 61.0 99 39.0 0 0.0
Arkansas 171 149 87.1 16 9.4 6 3.5
California 3,852 1,150 29.9 2,682 69.6 20 0.5
Colorado 79 40 50.6 35 44.3 4 5.1
Connecticut 128 66 51.6 62 48.4 0 0.0
Delaware 36 17 47.2 19 52.8 0 0.0
District of Columbia 107 71 66.4 33 30.8 3 2.8
Florida 1,302 901 69.2 397 30.5 4 0.3
Georgia 631 509 80.7 119 18.9 3 0.5
Hawaii 181 51 28.2 129 71.3 1 0.6
Idaho 14 9 64.3 5 35.7 0 0.0
Illinois 850 606 71.3 238 28.0 6 0.7
Indiana 188 149 79.3 35 18.6 4 2.1
Iowa 55 31 56.4 24 43.6 0 0.0
Kansas 56 26 46.4 30 53.6 0 0.0
Kentucky T79 161 89.9 13 7.3 5 2.8
Louisiana 380 349 91.8 29 7.6 2 0.5
Maine 13 10 76.9 3 23.1 0 0.0
Maryland 324 183 56.5 141 43.5 0 0.0
Massachusetts 262 93 33.0 188 66.7 1 0.4
Michigan 385 287 74.5 97 25.2 1 0.3
Minnesota 161 46 28.6 115 71.4 0 0.0
Mississippi 225 215 95.6 10 4.4 0 0.0
Missouri 184 149 81.0 34 18.5 1 0.5
Montana 20 20 100.0 0 0.0 0 0.0
Nebraska 31 12 38.7 19 61.3 0 0.0
Nevada 128 63 49.2 64 50.0 1 0.8
New Hampshire 14 9 64.3 5 35.7 0 0.0
New Jersey 640 319 49.8 321 50.2 0 0.0
New Mexico 68 47 69.1 21 30.9 0 0.0
New York 2,000 922 46.1 1,067 53.4 11 0.6
North Carolina 498 425 85.3 71 14.3 2 0.4
North Dakota 10 10 100.0 0 0.0 0 0.0
Ohio 230 174 75.7 55 23.9 1 0.4
Oklahoma 138 166 83.8 32 16.2 0 0.0
Oregon 156 79 50.6 77 49.4 0 0.0
Pennsylvania 448 334 74.6 113 25.2 1 0.2
Rhode Island 63 28 44.4 35 55.6 0 0.0
South Carolina 286 267 93.4 18 6.3 1 0.3
South Dakota 23 21 91.3 2 8.7 0 0.0
Tennessee 439 394 89.7 44 10.0 1 0.2
Texas 1,820 1,138 62.5 677 37.2 5 0.3
Utah 52 19 36.5 32 61.5 1 1.9
Vermont 5 4 80.0 1 20.0 0 0.0
Virginia 339 183 54.0 148 43.7 8 2.4
Washington 265 104 39.2 161 60.8 0 0.0
West Virginia 42 40 95.2 2 4.8 0 0.0
Wisconsin 109 71 65.1 38 34.9 0 0.0
Wyoming 4 3 75.0 1 25.0 0 0.0
(a)Persons bom outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, 
Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands, U.S. 
Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
Note: See Figure 5.
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________________________________Country of Origin_________________________________________
Unknown
Total Rep. of Rep. of All or
Table 10. Tuberculosis Cases in Foreign-born Persons(a) by Country of Origin: States, 1998
State Cases Mexico Philippines Vietnam India China Haiti Korea Others(b) Missing
United States 7,591 1,757 968 748 503 373 299 2T9 2,706 18
Alabama 22 7 1 5 3 1 1 0 4 0
Alaska 12 1 6 0 0 1 1 0 3 0
Arizona 99 69 4 6 3 0 0 1 16 0
Arkansas 16 7 1 1 2 0 0 0 5 0
California 2,682 844 564 332 110 153 1 106 561 11
Colorado 35 13 4 6 0 5 0 0 7 0
Connecticut 62 2 2 2 10 2 5 1 38 0
Delaware 19 1 2 0 2 2 4 0 8 0
District of Columbia 33 2 3 1 1 0 1 0 24 1
Florida 397 25 16 14 16 1 143 5 177 0
Georgia 119 37 1 14 7 1 2 4 53 0
Hawaii 129 1 96 6 0 10 0 7 9 0
Idaho 5 4 0 1 0 0 0 0 0 0
Illinois 238 50 37 10 46 9 0 6 79 1
Indiana 35 15 2 4 3 2 0 0 9 0
Iowa 24 3 1 3 6 0 0 2 9 0
Kansas 30 10 0 10 0 0 0 1 9 0
Kentucky 13 4 0 0 4 1 0 0 4 0
Louisiana 29 0 3 13 3 0 0 1 9 0
Maine 3 0 0 0 0 0 0 0 3 0
Maryland 141 1 19 17 16 2 4 7 75 0
Massachusetts 188 2 3 24 13 22 25 4 95 0
Michigan 97 11 6 a 24 3 0 5 40 0
Minnesota 115 5 5 12 4 10 0 2 77 0
Mississippi 10 0 2 4 3 0 0 0 1 0
Missouri 34 6 1 8 2 1 0 1 14 1
Montana 0 0 0 0 0 0 0 0 0 0
Nebraska 19 7 1 5 0 1 0 1 4 0
Nevada 64 27 18 0 0 2 1 1 15 0
New Hampshire 5 0 0 0 1 0 0 0 4 0
New Jersey 321 10 32 15 66 10 16 11 161 0
New Mexico 21 14 0 2 0 0 0 0 5 0
New York 1,067 50 43 26 65 106 88 25 662 2
North Carolina 71 28 4 3 5 0 0 0 31 0
North Dakota 0 0 0 0 0 0 0 0 0 0
Ohio 55 1 5 5 6 5 0 3 30 0
Oklahoma 32 14 1 1 5 1 0 1 9 0
Oregon 77 20 9 17 2 2 0 6 21 0
Pennsylvania 113 5 3 19 17 3 3 2 61 0
Rhode Island 35 0 2 2 0 1 3 0 27 0
South Carolina 18 7 0 1 1 3 0 1 5 0
South Dakota 2 0 0 1 0 0 0 0 1 0
Tennessee 44 6 1 10 3 1 0 2 21 0
Texas 677 401 17 67 27 3 0 4 156 2
Utah 32 5 2 6 0 2 0 1 16 0
Vermont 1 0 0 1 0 0 0 0 0 0
Virginia 148 4 18 31 11 3 1 5 75 0
Washington 161 27 33 33 9 4 0 3 52 0
West Virginia 2 1 0 0 0 0 0 0 1 0
Wisconsin 38 9 0 2 7 0 0 0 20 0
Wyoming 1 1 0 0 0 0 0 0 0 0
(a) Persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, 
Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands,
U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
(b) lncludes 149 countries.
Note: See Figure 5.
19
Table 11. Tuberculosis Cases in Foreign-born Persons(a) by Number of Years in the United States:
States, 1998______________________________________________________________________________
State
Total
Cases
<1 Year 1 ■4 5 -9 10- 19 20+
Unknown or 
Missing
No. % No. % No. % No. % No. % No. %
United States 7,591 1,266 16.7 1,448 19.1 1,135 15.0 1,264 16.9 970 12.6 1,488 19.6
Alabama 22 5 22.7 8 36.4 2 9.1 2 9.1 1 4.5 4 18.2
Alaska 12 1 8.3 0 0.0 1 8.3 0 0.0 0 0.0 10 83.3
Arizona 99 19 19.2 20 20.2 13 13.1 18 18.2 17 17.2 12 12.1
Arkansas 16 7 43.8 2 12.5 0 0.0 0 0.0 2 12.5 5 31.3
California 2,682 436 16.3 407 15.2 394 14.7 501 18.7 378 14.1 566 21.1
Colorado 35 6 17.1 5 14.3 7 20.0 4 11.4 4 11.4 9 25.7
Connecticut 62 15 24.2 13 21.0 4 6.5 13 21.0 2 3.2 15 24.2
Delaware 19 , 3 15.8 3 15.8 1 5.3 1 5.3 2 10.5 9 47.4
District of Columbia 33 2 6.1 6 18.2 2 6.1 1 3.0 0 0.0 22 66.7
Florida 397 46 11.6 61 15.4 42 10.6 80 20.2 39 9.8 129 32.5
Georgia 119 18 15.1 35 29.4 20 16.8 12 10.1 6 6.7 26 21.8
Hawaii 129 49 38.0 15 11.6 18 14.0 21 16.3 16 12.4 10 7.8
Idaho 5 0 0.0 1 20.0 3 60.0 0 0.0 0 0.0 1 20.0
Illinois 236 39 16.4 66 27.7 27 11,3 37 15.5 30 12.6 39 16.4
Indiana 35 3 8.6 8 22.9 3 8.6 2 5.7 0 0.0 19 54.3
Iowa 24 8 33.3 4 16.7 3 12.5 3 12.5 3 12.5 3 12.5
Kansas 30 4 13.3 8 26.7 1 3.3 5 16.7 4 13.3 8 26.7
Kentucky 13 3 23.1 2 15.4 1 7.7 0 0.0 2 15.4 5 38.5
Louisiana 29 3 10.3 5 17.2 3 10.3 5 17.2 3 10.3 10 34.5
Maine 3 0 0.0 2 66.7 0 0.0 1 33.3 0 0.0 0 0.0
Maryland 141 25 17.7 33 23.4 23 16.3 15 10.6 8 5.7 37 26.2
Massachusetts 186 32 17.0 45 23.9 38 20.2 49 26.1 21 11.2 3 1.6
Michigan 97 21 21.6 28 28.9 17 17.5 8 8.2 13 13.4 10 10.3
Minnesota 115 29 25.2 27 23.5 13 11.3 8 7.0 3 2.6 35 30.4
Mississippi 10 2 20.0 2 20.0 4 40.0 2 20.0 0 0.0 0 0.0
Missoun 34 8 23.5 7 20.6 4 11.8 4 11.8 1 2.9 10 29.4
Montana 0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Nebraska 19 4 21.1 2 10.5 2 10.5 1 5.3 3 15.8 7 36.8
Nevada 64 19 29.7 10 15.6 9 14.1 11 17.2 15 23.4 0 0.0
New Hampshire 5 2 40.0 2 40.0 0 0.0 0 0.0 1 20.0 0 0.0
New Jersey 321 41 12.8 90 28.0 61 19.0 46 14.3 33 10.3 50 15.6
New Mexico 21 7 33.3 1 4.8 2 9.5 2 9.5 8 38.1 1 4.8
New York 1,067 170 15.9 226 21.2 207 19.4 207 19.4 144 13.5 113 10.6
North Carolina 71 22 31.0 19 26.8 12 16.9 9 12.7 4 5.6 5 7.0
North Dakota 0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Ohio 55 13 23.6 15 27.3 5 9.1 9 16.4 6 10.9 7 12.7
Oklahoma 32 2 6.3 2 6.3 1 3.1 3 9.4 2 6.3 22 68.8
Oregon 77 12 15.6 17 22.1 12 15.6 13 16.9 5 6.5 18 23.4
Pennsylvania 113 16 14.2 20 17,7 15 13.3 10 8.8 8 7.1 44 38.9
Rhode Island 35 7 20.0 4 11.4 4 11.4 7 20.0 5 14.3 8 22.9
South Carolina 18 3 16.7 7 38.9 0 0.0 5 27.8 3 16.7 0 0.0
South Dakota 2 1 50.0 1 50.0 0 0.0 0 0.0 0 0.0 0 0.0
Tennessee 44 10 22.7 14 31.8 9 20.5 6 13.6 1 2.3 4 9.1
Texas 677 107 15.8 151 22.3 99 14.6 127 18.8 157 23.2 36 5.3
Utah 32 3 9.4 10 31.3 5 15.6 1 3.1 2 6.3 11 34.4
Vermont 1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 100.0
Virginia 148 1 0.7 1 0.7 0 0.0 0 0.0 0 0.0 146 98.6
Washington 161 35 21.7 31 19.3 40 24.6 29 18.0 12 7.5 14 8.7
west Virginia 2 1 50.0 0 0.0 1 50.0 0 0.0 0 0.0 0 0.0
Wisconsin 38 6 15.8 12 31.6 7 18.4 6 15.8 3 7.9 4 10.5
Wyoming 1 0 0.0 0 0.0 0 0.0 0 0.0 1 100.0 0 0.0
(a) Persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, 
Midway Island, the Commonwealth of tine Northern Mariana Islands, Puerto Rico, the Republic of Palau, U.S. Minor Outlying Islands,
U. S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
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Table 12. Tuberculosis Cases by Form of Disease: States, 1998
Cases with Both Pulmonary
State
Total
Cases
Pulmonaryfa) Extrapulmonarv(b)
and Exlraj 
Total(<
pulmonary Disease 
c) Miliary
No. % No. % No. — No.
United States 18,361 13,479 73.4 3,541 19.3 1,334 7.3 378
Alabama 381 305 80.1 60 15.7 16 4.2 4
Alaska 55 48 87.3 4 7.3 3 5.5 0
Anzona 254 192 75.6 44 17.3 18 7.1 4
Arkansas 171 131 76.6 25 14.6 14 8.2 4
California 3,852 2,842 73.8 738 19.2 272 7.1 85
Colorado 79 50 63.3 16 20.3 13 16.5 5
Connecticut 128 86 67.2 36 28.1 6 4.7 3
Delaware 36 27 75.0 5 13.9 4 11.1 1
District of Columbia 107 70 65.4 29 27.1 7 6.5 4
Florida 1,302 1,088 83.6 164 12.6 50 3.8 24
Georgia 631 483 76.5 108 17.1 40 63 10
Hawaii 181 141 77.9 33 18.2 7 3.9 3
Idaho 14 8 57.1 6 42.9 0 0.0 0
Illinois 850 661 77.8 157 18.5 32 3.8 7
Indiana 188 147 78.2 36 19.1 5 2.7 1
Iowa 55 33 60.0 21 38.2 1 1.8 1
Kansas 56 37 66.1 14 25.0 5 B.9 2
Kentucky 179 156 87.2 16 8.9 7 3.9 5
Louisiana 380 320 84.2 48 12.6 12 3.2 4
Maine 13 7 53.8 2 15.4 4 30.8 1
Maryland 324 208 64.2 77 23.8 38 11.7 20
Massachusetts 282 163 57.8 98 34.8 21 7.4 8
Michigan 385 261 67.8 107 27.8 17 4.4 2
Minnesota 161 91 56.5 58 36.0 12 7.5 3
Mississippi 225 178 79.1 38 16.9 9 4.0 1
Missoun 184 135 73.4 34 18.5 14 7.6 4
Montana 20 16 80.0 4 20.0 0 0.0 0
Nebraska 31 20 64.5 9 29.0 2 6.5 2
Nevada 128 111 86.7 14 10.9 3 2.3 1
New Hampshire 14 6 42.9 8 57.1 0 0.0 0
New Jersey 640 423 66.1 151 23.6 66 10.3 21
New Mexico 68 43 63.2 18 26.5 7 10.3 1
New York 2,000 1,360 68.0 387 19.3 252 12.6 62
North Carolina 498 386 77.5 83 16.7 29 5.8 11
North Dakota 10 6 60.0 2 20.0 2 20.0 1
Ohio 230 165 71.7 58 25.2 7 3.0 1
Oklahoma 198 148 74.7 35 17.7 15 7.6 3
Oregon 156 105 67.3 38 24.4 13 8.3 3
Pennsylvania 448 299 66.7 122 27.2 27 6.0 7
Rhode island 63 36 57.1 17 27.0 9 14.3 1
South Carolina 286 175 61.2 74 25.9 36 12.6 8
Soutn Dakota 23 12 52.2 6 26.1 5 21 7 1
Tennessee 439 322 73.3 79 18.0 38 8 7 6
Texas 1,820 1,378 75.7 291 16.0 151 8.3 34
Utah 52 34 65.4 14 26.9 4 7.7 0
Vermont 5 4 80.0 1 20.0 0 0.0 0
Virginia 339 263 77.6 66 19.5 10 2.9 3
Washington 265 181 68.3 62 23.4 22 8.3 4
West Virginia 42 35 83.3 6 14.3 1 2.4 0
Wisconsin 109 81 74.3 21 19.3 7 6.4 2
Wyoming 4 2 50.0 1 25.0 1 25.0 0
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 74 83.1 11 12.4 4 4.5 1
N. Manana Isiands(d)
Puerto Rico(d) 201 174 86.6 25 12.4 2 1.0 1
Republic of Palau(d) 
U.S. Virgin Islands(d)
(a) lncludes cases with pulmonary listed as major site of disease and no additional site of disease.
(b) lncludes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major site 
of disease.
(c) Includes miliary cases.
(d) Not included in totals.
Ellipses indicate data not available.
Note:7(<0.1%) cases had missing and/or unknown site of disease.
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Table 13. Extrapulmonary Tuberculosis Cases by Site of Disease: States, 1998
Total
Extra- Site of Disease
pulmonary Bone and/ Genito-
State Cases Pleural Lymphatic or Joint urinary Meningeal Peritoneal Other
United States 3,541 736 1,417 377 247 177 158 429
Alabama 60 15 16 11 2 3 4 9
Alaska 4 0 3 0 1 0 0 0
Arizona 44 6 18 8 1 3 4 4
Arkansas 25 8 2 7 2 1 1 4
California 738 128 332 76 56 34 38 74
Colorado 16 1 7 2 1 0 1 4
Connecticut 36 4 24 1 2 2 2 1
Delaware 5 1 3 0 1 0 0 0
District of Columbia 29 8 8 2 2 4 2 3
Florida 164 34 63 15 11 6 6 29
Georgia 108 33 38 10 5 1 7 14
Hawaii 33 9 16 3 1 0 1 3
Idaho 6 1 0 1 2 1 0 1
Illinois 157 29 57 14 9 9 9 30
Indiana 36 12 9 4 3 4 1 3
Iowa 21 10 5 3 1 1 0 1
Kansas 14 2 6 2 2 0 0 2
Kentucky 16 7 6 0 1 0 0 2
Louisiana 48 11 16 4 4 5 2 6
Maine 2 0 1 0 0 0 0 1
Maryland 77 26 30 10 2 4 3 2
Massachusetts 98 21 53 5 3 3 3 10
Michigan 107 20 53 16 6 5 5 2
Minnesota 58 8 16 4 2 3 5 20
Mississippi 38 15 5 4 3 1 2 8
Missouri 34 9 15 5 2 0 2 1
Montana 4 0 2 1 1 0 0 0
Nebraska 9 1 3 2 0 0 0 3
Nevada 14 3 5 1 0 1 1 3
New Hampshire 8 2 3 2 1 0 0 0
New Jersey 151 27 72 11 15 8 8 10
New Mexico 18 2 B 3 2 1 1 1
New York 387 60 159 52 36 28 15 37
North Carolina 83 32 22 7 2 6 2 12
North Dakota 2 0 0 1 0 0 0 1
Ohio 58 18 18 6 4 2 2 8
Oklahoma 35 10 15 3 1 4 0 2
Oregon 38 7 13 3 3 3 2 7
Pennsylvania 122 21 36 22 11 7 2 23
Rhode Island 17 0 9 0 1 1 1 5
South Carolina 74 24 26 4 7 3 3 7
South Dakota 6 2 3 0 0 0 0 1
Tennessee 79 19 31 14 2 5 1 7
Texas 291 61 113 21 26 15 13 42
Utah 14 0 7 0 2 0 1 4
Vermont 1 0 1 0 0 0 0 0
Virginia 66 11 31 6 3 3 2 10
Washington 62 10 32 6 2 0 4 8
West Virginia 6 1 0 3 1 0 0 1
Wisconsin 21 6 6 2 2 0 2 3
Wyoming 1 1 0 0 0 0 0 0
American Samoa(a)
Fed. States of Micronesia(a) 
Guam(a)
N. Manana Islands(a)
11 3 1 1 3 0 2 ' l
Puerto Rico(a) 
Republic of Palau(a) 
U.S. Virgin Islands(a)
25 9 9 i 6 0 1 5
(a)Not included in totals.
Ellipses indicate data not available. 
Note: See Figure 6.
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Table 14. Tuberculosis Cases in Residents of Correctional Facilities: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with Information on 
Resident of Correctional Facility 
--------No!----------— -------------
Percent of Cases in Residents 
of Correctional Facilities(a)
United States 18,361 18,260 99.4 3.6 (b)
Alabama 381 381 100.0 3.1
Alaska 55 55 100.0 1.8
Arizona 254 254 100.0 5.5
Arkansas 171 136 79.5 0.0
California 3,852 3,840 99.7 3.6
Colorado 79 75 94.9 1.3
Connecticut 128 128 100.0 4.7
Delaware 36 36 100.0 0.0
District of Columbia 107 107 100.0 5.6
Florida 1,302 1,301 99.9 4.5
Georgia 631 631 100.0 4.9
Hawaii 181 181 100.0 0.0
Idaho 14 14 100.0 7.1
Illinois 850 845 99.4 2.8
Indiana 188 188 100.0 3.2
Iowa 55 55 100.0 0.0
Kansas 56 52 92.9 1.9
Kentucky 179 178 99.4 3.4
Louisiana 380 376 98.9 5 1
Maine 13 13 100.0 0.0
Maryland 324 322 99.4 1.2
Massachusetts 282 281 99.6 1.8
Michigan 385 384 99.7 0.8
Minnesota 161 159 98.8 1.3
Mississippi 225 225 100.0 0.9
Missouri 184 181 98.4 1.7
Montana 20 20 100.0 0.0
Nebraska 31 31 100.0 00
Nevada 128 128 100.0 3.1
New Hampshire 14 14 100.0 0.0
New Jersey 640 640 100.0 0.9
New Mexico 68 68 100.0 4.4
New York State(c) 442 442 100.0 5.7
New York City 1,558 1,558 100.0 2.8
North Carolina 498 490 98.4 1.6
North Dakota 10 10 100.0 0.0
Ohio 230 230 100.0 2.2
Oklahoma 198 198 100.0 3.5
Oregon 156 154 98.7 5.2
Pennsylvania 448 448 100.0 3.3
Rhode Island 63 63 100.0 1.6
South Carolina 286 286 100.0 2.1
South Dakota 23 23 100.0 0.0
Tennessee 439 438 99.8 3.2
Texas 1,820 1,805 99.2 8.3
Utah 52 52 100.0 1.9
Vermont 5 5 100.0 0.0
Virginia 339 339 100.0 2.4
Washington 265 265 100.0 2.3
West Virginia 42 42 100.0 2.4
Wisconsin 109 109 100.0 2.8
Wyoming 4 4 100.0 0.0
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 88 98.9 0.0
N. Mariana Islands(d)
Puerto Rico(d) 201 200 99.5 1.5
Republic of Palau(d)
U.S. Virgin Islands(d)
(a) Resident of correctional facility at time of diagnosis. Percentages shown only for reporting areas with information reported for 
>75% cases.
(b) Percentage based on data from 52 areas reporting information on resident of correctional facility for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 15. Tuberculosis Cases by Homeless Status: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with Information 
on Homeless Status 
— R o---------------------------
Percent of Cases in 
Homeless Persons(a)
United States 18,361 17,943 97.7 6.3 (b)
Alabama 381 379 99.5 5.0
Alaska 55 55 100.0 16.4
Arizona 254 252 99.2 11.9
Arkansas 171 128 75.0 3.9
California 3,852 3,774 98.0 6.4
Colorado 79 73 92.4 8.2
Connecticut 128 116 90.6 10.3
Delaware 36 36 100.0 2.8
District of Columbia 107 106 99.1 11.3
Florida 1,302 1,296 99.5 10.0
Georgia 631 622 98.6 7.7
Hawaii 181 181 100.0 0.0
idaho 14 11 78.6 9.1
Illinois 850 822 96.7 5.6
Indiana 188 176 93.6 4.0
Iowa 55 55 100.0 9.1
Kansas 56 51 91.1 0.0
Kentucky 179 166 92.7 8.4
Louisiana 380 354 93.2 7.1
Maine 13 13 100.0 0.0
Maryland 324 323 99.7 2.5
Massachusetts 282 277 98.2 3.2
Michigan 385 356 92.5 2.5
Minnesota 161 157 97.5 4.5
Mississippi 225 225 100.0 0.9
Missouri 184 175 95.1 13.7
Montana 20 20 100.0 15.0
Nebraska 31 29 93.5 6.9
Nevada 128 126 98.4 7.9
New Hampshire 14 14 100.0 0.0
New Jersey 640 640 100.0 4.5
New Mexico 68 68 100.0 1.5
New York State(c) 442 437 98.9 3.4
New York City 1,558 1,549 99.4 5.5
North Carolina 498 490 98.4 6.7
North Dakota 10 10 100.0 0.0
Ohio 230 228 99.1 7.5
Oklahoma 198 198 100.0 7.6
Oregon 156 151 96.8 13.2
Pennsylvania 448 432 96.4 2.8
Rhode Island 63 63 100.0 0.0
South Carolina 286 279 97.6 3.6
South Dakota 23 23 100.0 4.3
Tennessee 439 432 98.4 7.6
Texas 1,820 1,808 99.3 6.6
Utah 52 52 100.0 17.3
Vermont 5 5 100.0 0.0
Virginia 339 295 87.0 2.0
Washington 265 263 99.2 10.6
West Virginia 42 40 95.2 2.5
Wisconsin 109 108 99.1 3.7
Wyoming 4 4 100.0 25.0
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 86 96.6 1.2
N. Mariana Islands(d)
Puerto Rico(d) 201 201 100.0 5.6
Republic of Palau(d)
U.S. Virgin Isiands(d)
(a) Homeless within past 12 months. Percentages shown only for reporting areas with information reported for >75% of cases.
(b) Percentage based on data from 62 areas reporting information on homeless status lo r >75% of cases.
(c) Exdudes New York City.
(d) Not included in totals.
Ellipses indicate data not available
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Table 16. Tuberculosis Cases in Residents of Long-term Care Facilities: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with Information on 
Resident of Long-term Care Facilities
No. %
Percent of Cases in Residents 
of Long-term Care Facilities(a)
United States 18,361 18,236 99.3 3.5 (b)
Alabama 381 378 99.2 2.1
Alaska 55 55 100.0 0.0
Arizona 254 254 100.0 2.0
Arkansas 171 137 80.1 12.4
California 3,852 3,844 99.8 3.6
Colorado 79 77 97.5 3.9
Connecticut 128 128 100.0 7.8
Delaware 36 36 100.0 19.4
District of Columbia 107 107 100.0 1.9
Florida 1,302 1,302 100.0 2.4
Georgia 631 630 99.8 3.2
Hawaii 181 181 100.0 1.1
Idaho 14 14 100.0 0.0
Illinois 850 845 99.4 4.6
Indiana 188 186 100.0 2.7
Iowa 55 54 98.2 1.9
Kansas 56 52 92.9 5.8
Kentucky 179 177 98.9 15.3
Louisiana 380 374 98.4 2.4
Maine 13 13 100.0 0.0
Maryland 324 322 99.4 3.7
Massachusetts 282 282 100.0 4.3
Michigan 385 383 99.5 3.7
Minnesota 161 159 98.8 3.1
Mississippi 225 225 100.0 4.9
Missouri 184 181 98.4 12.7
Montana 20 20 100.0 0.0
Nebraska 31 31 100.0 3.2
Nevada 128 128 100.0 2.3
New Hampshire 14 14 100.0 7.1
New Jersey 640 640 100.0 1.6
New Mexico 68 68 100.0 1.5
New York State(c) 442 442 100.0 2.7
New York City 1,558 1,556 99.9 1.7
North Carolina 498 470 94.4 4.0
North Dakota 10 10 100.0 0.0
Ohio 230 230 100.0 6.1
Oklahoma 198 198 100.0 2.5
Oregon 156 154 98.7 3.9
Pennsylvania 448 448 100.0 5.1
Rhode Island 63 63 100.0 4.8
South Carolina 286 286 100.0 3.5
South Dakota 23 23 100.0 17.4
Tennessee 439 438 99.8 5.9
Texas 1,820 1,803 99.1 2.6
Utah 52 52 100.0 1.9
Vermont 5 5 100.0 0 0
Virginia 339 339 100.0 4.4
Washington 265 265 100.0 1.5
West Virginia 42 42 100.0 0.0
Wisconsin 109 109 100.0 4.6
Wyoming 4 4 100.0 0.0
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 88 98.9 o.o
N. Mariana Islands(d)
Puerto Rico(d) 201 200 99.5 3.6
Republic of Palau(d)
U.S. Virgin Islands(d)
(a) Resident of long-term care facility at time of diagnosis. Percentages shown only for reporting areas with information reported for 
>75% of cases.
(b) Percentage based on data from 52 areas reporting information on resident of long-term care facility for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 17. Tuberculosis Cases by Injecting Drug Use: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with Information on 
Injecting Drug Use 
---------K E ------ JL=L- * --------W ~
Percent of Cases in 
Iniectirrq Drug Users(a)
United States 18,361 16,849 91.8 2.9 <b)
Alabama 381 338 88.7 1.2
Alaska 55 33 60.0 -
Arizona 254 246 96.9 2.4
Arkansas 171 120 70.2 «
California 3,852 3,574 92.8 3.1
Colorado 79 59 74.7
Connecticut 128 113 88.3 3.5
Delaware 36 33 91.7 0.0
District or Columbia 107 84 78.5 4.8
Florida 1,302 1,237 95.0 2.1
Georgia 631 509 80.7 1.0
Hawaii 181 118 65.2 —
Idaho 14 10 71.4 —
Illinois 850 692 81.4 2.5
Indiana 188 129 68.6
Iowa 55 40 72.7 -
Kansas 56 42 75.0 0.0
Kentucky 179 161 89.9 4.3
Louisiana 380 340 89.5 6.8
Maine 13 13 100.0 0.0
Maryland 324 310 95.7 4.8
Massachusetts 282 235 83.3 1.7
Michigan 385 329 85.5 0.9
Minnesota 161 157 97.5 0.6
Mississippi 225 225 100.0 1.3
Missoun 184 159 86.4 3.1
Montana 20 18 90.0 0.0
Nebraska 31 29 93.5 0.0
Nevada 128 123 96.1 0.8
New Hampshire 14 13 92.9 0.0
New Jersey 640 640 100.0 6.9
New Mexico 68 68 100.0 1.5
New York State(c) 442 412 93.2 2.9
New York City 1,558 1,506 96.7 3.3
North Carolina 498 480 96.4 1.2
North Dakota 10 8 80.0 0.0
Ohio 230 226 98.3 0.9
Oklahoma 198 197 99.5 3.0
Oregon 156 142 91.0 8.5
Pennsylvania 448 391 87.3 4.3
Rhode Island 63 60 95.2 0.0
South Carolina 286 251 87.8 1.2
South Dakota 23 23 100.0 0.0
Tennessee 439 410 93.4 3.2
Texas 1,820 1,762 96.8 3.6
Utah 52 45 86.5 6.7
Vermont 5 1 20.0 -
Virginia 339 339 100.0 1.5
Washington 265 252 95.1 1.2
West Virginia 42 37 88.1 0.0
Wisconsin 109 108 99.1 1.9
Wyoming 4 2 50.0 -
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 82 92.1 1.2
N. Manana Isiands(d)
Puerto Rico(d) 201 201 100.0 18.9
Republic ol Palau(d)
U.S. Virgin Islands(d)
(a) lnjecting drug use within past 12 months. Percentages shown only for reporting areas with information reported for >75% of cases.
(b) Percentage based on data from 43 areas reporting information on injecting drug use for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 18. Tuberculosis Cases by Noninjecting Drug Use: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with Information on 
Noniniectinq Druq Use 
No. %
Percent of Cases in 
Noninjecting Drug Usersfa)
United States 18,361 16,730 91.1 7.7 (b)
Alabama 381 340 89.2 6.2
Alaska 55 31 56.4 -
Arizona 254 245 96.5 4.1
Arkansas 171 118 69.0 --
California 3,852 3,559 92.4 7.4
Colorado 79 57 72.2 -
Connecticut 12B 107 83.6 6.5
Delaware 36 31 86.1 9.7
District ol Columbia 107 81 75.7 7.4
Flonda 1,302 1,228 94.3 12.4
Georgia 631 510 80.8 12.0
Hawaii 181 120 66.3 —
Idaho 14 9 64.3 —
Illinois 850 687 80.8 12.2
Indiana 188 129 68.6
Iowa 55 39 70.9 - -
Kansas 56 41 73.2 -
Kentucky 179 160 89.4 5.6
Louisiana 380 328 86 3 17.1
Maine 13 13 100 0 0.0
Maryland 324 299 92.3 2.7
Massachusetts 282 231 81.9 3.5
Michigan 385 327 84.9 3.4
Minnesota 161 157 97.5 1.9
Mississippi 225 225 100.0 6.2
Missouri 184 160 87.0 125
Montana 20 17 85.0 0 0
Nebraska 31 29 93.5 0.0
Nevada 128 119 93.0 3.4
New Hampshire 14 13 92.9 0.0
New Jersey 640 640 100.0 9.8
New Mexico 68 64 94.1 1.6
New York State(c) 442 411 93.0 5.8
New York City 1,558 1,509 96 9 9.3
North Carolina 498 464 93 2 8.0
North Dakota 10 7 70.0 -
Ohio 230 223 97.0 9.4
Oklahoma 198 191 96.5 0.5
Oregon 156 138 88.5 10.1
Pennsylvania 448 388 86.6 7.0
Rhode Island 63 61 96.8 3.3
South Carolina 286 249 87.1 8.4
South Dakota 23 23 100.0 0.0
Tennessee 439 415 94.5 9 4
Texas 1,820 1,759 96.6 5.0
Utah 52 44 84.6 9.1
Vermont 5 1 20.0 --
Virginia 339 336 99.1 2.1
Washington 265 250 94.3 1.6
West Virginia 42 36 85.7 00
Wisconsin 109 108 99.1 8 3
Wyoming 4 3 75.0 33.3
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 82 92.1 o.o
N. Mariana Islands(d)
Puerto Rico(d) 201 201 100.0 13.9
Republic of Palau(d)
U.S. Virgin Islands(d)
(a) Noninjecting drug use within past 12 months. Percentages shown only for reporting areas with information reported for 
>75% of cases
(b) Percentage based on data from 42 areas reporting information on noninjecting drug use for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 19. Tuberculosis Cases by Excess Alcohol Use: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with Information on 
Excess Alcohol Use 
Fla %
Percent of Cases in Persons 
with Excess Alcohol Use(a)
United States 18,361 16,717 91.0 16.0 (b)
Alabama 381 323 84.8 22.3
Alaska 55 42 76.4 45.2
Arizona 254 246 96.9 16.3
Arkansas 171 117 68.4 —
California 3,852 3,551 92.2 12.3
Colorado 79 56 70.9 -
Connecticut 128 103 80.5 16.5
Delaware 36 32 88.9 15.6
District of Columbia 107 84 78.5 13.1
Florida 1,302 1,231 94.5 24.5
Georgia 631 519 82.3 23.9
Hawaii 181 121 66.9
Idaho 14 12 85.7 25.0
Illinois 850 688 80.9 18.9
Indiana 188 125 66.5 -
Iowa 55 41 74.5 -
Kansas 56 42 75.0 4.8
Kentucky 179 163 91.1 14.1
Louisiana 380 322 84.7 30.4
Maine 13 13 100.0 7.7
Maryland 324 293 90.4 15.4
Massachusetts 282 231 81.9 12.6
Michigan 385 330 85.7 12.1
Minnesota 161 156 96.9 8.3
Mississippi 225 225 100.0 17.8
Missouri 184 160 87.0 20.0
Montana 20 18 90.0 44.4
Nebraska 31 24 77.4 12.5
Nevada 128 121 94.5 7.4
Now Hampshire 14 13 92.9 7.7
New Jersey 640 640 100.0 14.5
New Mexico 68 64 94.1 12.5
New York State(c) 442 409 92.5 12.5
New York City 1,558 1,508 96.8 10.8
North Carolina 498 445 89.4 26.1
North Dakota 10 8 80.0 12.5
Ohio 230 225 97.8 20.4
Oklahoma 198 197 99.5 11.2
Oregon 156 136 87.2 14.0
Pennsylvania 448 386 86.2 14.8
Rhode Island 63 62 98.4 6.5
South Carolina 286 253 88.5 27.3
South Dakota 23 23 100.0 30.4
Tennessee 439 406 92.5 20.4
Texas 1,820 1,770 97.3 16.2
Utah 52 43 82.7 11.6
Vermont 5 2 40.0
Virginia 339 339 100.0 4.4
Washington 265 253 95.5 5.9
West Virginia 42 35 83.3 14.3
Wisconsin 109 108 99.1 23.1
Wyoming 4 3 75.0 33.3
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 82 92.1 0.0
N. Mariana Isiands(d)
Puerto Rico(d) 201 201 100.0 19.9
Republic of Palau(d)
U S. Virgin Islands(d)
(a) Excess alcohol use within past 12 months. Percentages shown only for reporting areas with information reported for >75% of 
cases.
(b) Percentage based on data from 46 areas reporting information on excess alcohol use for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 20. Tuberculosis Cases by Initial Drug Regimen: 59 Reporting Areas, 1998
Cases with Information on
Total Initial Drug Regimen Percent of Cases with Initial Drug Regimen (a)
Reporting Area Cases No. % — [R-------------- IRZ IRZ,E/S(b)
United States 18,361 18,175 99.0 2.5 (c) 12.3 (c) 68.9 (c)
Alabama 381 381 100.0 3.1 68.8 20.7
Alaska 55 55 100.0 0.0 1.8 94.5
Arizona 254 252 99.2 1.2 9.5 70.6
Arkansas 171 163 95.3 44.2 38.7 11.0
California 3,852 3,821 99.2 1.9 8.1 80.4
Colorado 79 76 96.2 2.6 10.5 76.3
Connecticut 128 122 95.3 4.1 16.4 70.5
Delaware 36 36 100.0 0.0 8.3 80.6
District of Columbia 107 102 95.3 0.0 2.9 63.7
Florida 1,302 1,300 99.8 1.5 11.3 74.8
Georgia 631 628 99.5 0.8 14.6 73.7
Hawaii 181 180 99.4 7.2 16.1 62.8
Idaho 14 14 100.0 0.0 28.6 64.3
Illinois 850 848 99.8 2.4 9.0 73.6
Indiana 188 188 100.0 5.3 186 60.6
Iowa 55 52 94.5 0.0 21.2 63.5
Kansas 56 52 92.9 3.8 13.5 76.9
Kentucky 179 175 97.8 5.7 14.9 68.0
Louisiana 380 375 98.7 2.7 15.7 69.3
Maine 13 13 100.0 0.0 23 1 61.5
Maryland 324 317 97.8 0.3 4.4 86.4
Massachusetts 282 278 98.6 1.8 4.3 83.1
Michigan 385 385 100.0 7.0 28.6 54.8
Minnesota 161 157 97.5 1.9 18.5 55.4
Mississippi 225 225 100.0 0.9 15.6 79.6
Missouri 184 183 99.5 1.6 7.1 68.3
Montana 20 20 100.0 0.0 25.0 70.0
Nebraska 31 31 100.0 3.2 29.0 41.9
Nevada 128 127 99.2 0.8 3.9 85.8
New Hampshire 14 14 100.0 0.0 21.4 71.4
New Jersey 640 635 99.2 2.0 10.7 69.6
New Mexico 68 64 94.1 0.0 34.4 56.3
New York State(d) 442 442 100.0 2.3 5.9 77.6
New York City 1,558 1,558 100.0 1.2 3.8 81.6
North Carolina 498 479 96.2 0.8 6.1 87.9
North Dakota 10 10 100.0 0.0 20.0 50.0
Ohio 230 230 100.0 3.0 33.0 49.1
Oklahoma 198 198 100.0 12.6 17.7 54.0
Oregon 156 150 96.2 0.7 6.0 82.0
Pennsylvania 448 447 99.8 2.7 10.5 72.9
Rhode Island 63 60 95.2 1.7 3.3 85.0
South Carolina 286 285 99.7 3.2 21.4 56.1
South Dakota 23 23 100 0 0.0 39.1 34.8
Tennessee 439 435 99.1 2.8 27.6 57.9
Texas 1,820 1,775 97.5 0.7 6.9 36.6
Utah 52 52 100.0 1.9 5.8 80.8
Vermont 5 5 100.0 0.0 20.0 80.0
Virginia 339 337 99.4 5.0 19.3 64.1
Washington 265 265 100.0 1.5 10.6 79.6
West Virginia 42 42 100.0 7.1 35.7 40.5
Wisconsin 109 109 100.0 2.8 15.6 73.4
Wyoming 4 4 100.0 0.0 25.0 50.0
American Samoa(e)
Fed. States ol Micronesia(e)
Guam(e) 89 89 100.0 o.o 0.0 84.3
N. Mariana Islands(e)
Puerto Rico(e) 201 198 98.5 1.5 6.1 77.8
Republic of Palau(e) 
U.S. Virgin Islands(e)
(a) Percentages shown only foi reporting areas with information reported for >75% of cases.
(b) Msoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol; S=streptomycin.
(c) Percentage based on data from 52 areas reporting information on initial drug regimen for >75% of cases.
(d) Excludes New York City.
(e) Not included in totals.
Ellipses indicate data not available.
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Total Cases with Initial
Table 21. Isoniazid-Resistant Tuberculosis Cases with or without Rifampin Resistance: 59 Reporting
Areas, 1998
Culture Drug Susceptibility Resistance(a)
Positive Testing Performed Isoniazid Isoniazid and Rifampin
Reporting Area Cases No. % — NoT------------ %------- No.
United States 14,830 13,477 90.9 1,060 8.0 (b) 145 1.1 (b)
Alabama 331 278 84.0 11 4.0 0 0.0
Alaska 51 51 100.0 1 2.0 0 0.0
Arizona 208 204 98.1 11 5.4 1 0.5
Arkansas 136 79 58.1 — -- — --
California 2,998 2,849 95.0 339 11.9 36 1.3
Colorado 71 67 94.4 7 10.4 0 0.0
Connecticut 111 108 97.3 8 7.4 1 0.9
Delaware 23 23 100.0 6 26.1 0 0.0
District of Columbia 99 68 68.7 — -- -- —
Florida 1,182 1,042 88.2 116 11.1 10 1.0
Georgia 505 433 85.7 25 5.8 1 0.2
Hawaii 139 134 96.4 16 11.9 1 0.7
Idaho 13 9 69.2 — — — -
Illinois 679 638 94.0 35 5.5 7 1.1
Indiana 142 120 84.5 8 6.7 1 0.8
Iowa 46 45 97.8 0 0.0 0 0.0
Kansas 47 44 93.6 5 11.4 1 2.3
Kentucky 153 127 83.0 5 3.9 1 0.8
Louisiana 304 291 95.7 18 6.2 1 0.3
Maine 12 12 100.0 0 0.0 0 0.0
Maryland 246 231 93.9 17 7.4 2 0.9
Massachusetts 223 217 97.3 18 8.3 1 0.5
Michigan 316 315 99.7 19 6.0 5 1.6
Minnesota 136 102 75.0 11 10.8 0 0.0
Mississippi 162 158 97.5 8 5.1 1 0.6
Missouri 151 134 88.7 7 5.2 0 0.0
Montana 18 16 88.9 1 6.3 0 0.0
Nebraska 31 27 87.1 2 7.4 2 7.4
Nevada 77 29 37.7 -- — -- -
New Hampshire 12 12 100.0 2 16.7 0 0.0
New Jersey 496 485 97.8 52 10.7 9 1.9
New Mexico 61 59 96.7 3 5.1 1 1.7
New York State(c) 310 307 99.0 20 6.5 4 1.3
New York City 1,257 1,215 96.7 105 8.6 34 2.8
North Carolina 410 396 96.6 22 5.6 4 1.0
North Dakota 10 9 90.0 0 0.0 0 0.0
Ohio 193 170 88.1 6 3.5 2 1.2
Oklahoma 153 137 89.5 5 3.6 0 0.0
Oregon 130 128 98.5 11 8,6 2 1.6
Pennsylvania 3t9 324 90.3 24 7.4 2 0.6
Rhode island 44 40 90.9 4 10.0 0 0.0
South Carolina 214 184 86.0 5 2.7 0 0.0
South Dakota 18 18 100.0 1 5.6 0 0.0
Tennessee 359 339 94.4 14 4.1 2 0.6
Texas 1,417 1,314 89.0 59 4.5 13 1.0
U U i 48 48 100.0 3 6.3 0 0.0
Vermont 5 2 40.0 — — -- —
Virginia 304 97 31.9 - - --
Washington 213 202 94.8 18 8.9 0 0.0
West Virginia 42 36 85.7 2 5.6 0 0.0
Wisconsin 103 102 99.0 10 9.8 0 0.0
Wyoming 2 2 100.0 0 0.0 0 0.0
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 62 59 95.2 5 8.5 i 1.7
N. Mariana Islands(d)
Puerto Rico(d) 113 161 93.1 14 8.7 3 1.9
Republic of Palau(d) 
U.S, Virgin Islands(d)
(a) Percentages shown only for reporting areas with information reported for >75% of cases. Isolates may be resistant to other drugs.
(b) Percentages based on data from 46 areas repotting information on initial drug susceptibility results for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 22. Tuberculosis Cases, Age 25 - 44, by HIV Status: 59 Reporting Areas, 1998
Reporting Area
Total
Cases
Cases with information 
on HIV Statu slat 
No. %
Percent of Cases in 
HIV-Positive Persons(b)
United States 6,365 3,509 55.1 -
Alabama 107 85 79.4 12.9
Alaska 26 11 42.3 —
Arizona 69 51 73.9 -
Arkansas 32 22 68.8 -
California 1,275 0 0.0 -
Colorado 26 23 88.5 21.7
Connecticut 50 26 52.0 —
Delaware 13 11 84.6 36.4
District of Columbia 48 35 72.9
Florida 544 457 84.0 46.8
Georgia 228 174 76.3 29.9
Hawaii 46 0 0.0 —
Idaho 6 2 33.3 --
Illinois 319 134 42.0 -
Indiana 48 8 16.7
Iowa 15 9 60.0 —
Kansas 17 8 47.1 -
Kentucky 38 16 42.1 -
Louisiana 132 103 76.0 18.4
Maine 3 3 100.0 33.3
Maryland 112 92 82.1 28.3
Massachusetts 108 38 35.2 —
Michigan 123 50 40.7 -
Minnesota 60 29 48.3 --
Mississippi 55 55 100.0 14.5
Missouri 53 34 64.2 —
Montana 4 3 75.0 0.0
Nebraska 12 2 16.7
Nevada 48 45 93.8 22.2
New Hampshire 2 0 0.0 -
New Jersey 260 151 58.1 -
New Mexico 14 11 78.6 27.3
New York State{c) 150 96 64.0 -
New York City 652 548 84.0 39.6
North Carolina 152 134 88.2 24.6
North Dakota 2 2 100.0 0.0
Ohio 62 51 82.3 7.8
Oklahoma 53 17 32 1 -
Oregon 71 60 84.5 13.3
Pennsylvania 137 62 59.9 -
Rhode Island 16 0 0.0
South Carolina 78 59 75.6 8.5
South Dakota 4 1 25.0
Tennessee 120 107 89.2 21.5
Texas 698 497 71.2 -
Utah 24 12 50.0
Vermont 1 1 100.0 0.0
Virginia 121 72 59.5 -
Washington 89 47 52.8 -
West Virginia 8 4 50.0 —
Wisconsin 32 29 90.6 6.9
Wyoming 2 2 100.0 0.0
American Samoa(d)
Fed. States of Micronesia(d) 
Guam(d)
N. Mariana Islands(d)
Puerto Rico(d)
Republic of Palau{d)
U.S. Virgin Islands(d)
20
72
6
56
30.0
77.8 55.4
{a)lncludes only those cases with negative, positive, and indeterminate HIV test results. 
(b)Percentages shown only lor reporting areas with information reported for >75% of cases.
(c) Excludes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 23. Tuberculosis Cases by Occupation: 59 Reporting Areas, 1998
Cases with Percent of C a ses  by Occupationfa)
information Unemployed Health
Total on Occupation Past Care Correctional Migrant Other Multiple
Reporting Area Cases No. ------- 24 Mos. Worker Employee Worker Occupation Occupations
United States 18,361 16,960 92.5 59.3 (b) 3.0 (b) 0.1 (b) 1.2 (b) 36.2 (b) 0.2 (b)
Alabama 381 355 93.2 68.7 2.3 0.0 0.0 29.0 0.0
Alaska 55 28 50.9 - - - — - —
Arizona 254 249 98.0 68.3 0.8 0.4 1.6 28.5 0.4
Arkansas 171 129 75.4 76.7 3.9 0.6 0.0 18.6 0.0
California 3,852 3,582 93.0 59.5 2.2 0.2 1.9 36.2 0.1
Colorado 79 64 81.0 53,1 4.7 0.0 1.6 40.6 0.0
Connecticut 128 122 95.3 54.9 6.6 0.0 2.5 35.2 0.8
Delaware 36 35 97.2 45.7 2.9 0.0 5.7 45.7 0.0
District of Columbia 107 100 93.5 78.0 0.0 0.0 0.0 22.0 0.0
Florida 1,302 1,251 96.1 48.7 2.6 0.0 2.2 46.4 0.1
Georgia 631 518 82.1 58.7 1.5 0.2 2.7 36.5 0.4
Hawaii 181 156 86.2 68.6 2.6 0.0 0.0 28.8 0.0
Idaho 14 14 100.0 35.7 7.1 0.0 21.4 35.7 0.0
Illinois 850 760 89.4 59.1 3.4 0,1 0.3 37,0 0.1
Indiana 188 164 87.2 64.0 3.0 0.0 0.6 31.7 0.6
Iowa 55 49 89.1 40.8 2.0 0.0 0.0 57.1 0.0
Kansas 56 51 91.1 45.1 3.9 0.0 2.0 49.0 0.0
Kentucky 179 167 93.3 78.4 1.2 0.0 2.4 18.0 0.0
Louisiana 380 320 84.2 64.7 1.6 0.0 0.0 33.8 0.0
Maine 13 13 100.0 84.6 0.0 0.0 0.0 15.4 0.0
Maryland 324 294 90.7 53.1 5.8 0.0 0.0 40.8 0.3
Massachusetts 282 262 92.9 51.1 6.5 0.0 0.0 42.4 0.0
Michigan 385 314 81.6 62.4 6.1 0.0 1.0 30.3 0.3
Minnesota 161 151 93.8 61.6 2.6 0.0 0.7 35.1 0.0
Mississippi 225 225 100.0 61.3 2.2 0.4 0.0 36.0 0.0
Missouri 184 164 89.1 62.2 4.3 0.0 0.0 33.5 0.0
Montana 20 20 100.0 85.0 0.0 0.0 0.0 15.0 0.0
Nebraska 31 31 100.0 45.2 3.2 0.0 0.0 51.6 0.0
Nevada 128 119 93.0 56.3 2.5 0.0 0.0 41.2 0.0
New Hampshire 14 14 100.0 78.6 0.0 0.0 0.0 21.4 0.0
New Jersey 640 640 100.0 62.7 5.5 0.0 0.5 30.8 0.6
New Mexico 68 61 89.7 62.3 0.0 0.0 0.0 37.7 0.0
New York State(c) 442 383 86.7 60.1 3.4 0.0 0.5 36.0 0.0
New York City 1,558 1,482 95.1 67.9 4.0 0.0 0.0 27.9 0.1
North Carolina 498 480 96.4 54.0 3.1 0.4 3.5 38.8 0.2
North Dakota 10 8 80.0 75.0 0.0 0.0 0.0 25.0 0.0
Ohio 230 227 98.7 68.7 5.3 0.0 0.4 25.6 0.0
Oklahoma 198 165 83.3 62.4 3.0 0.0 0.0 34.5 0.0
Oregon 156 138 88.5 47.1 1.4 0.0 2.9 48.6 0.0
Pennsylvania 448 392 87.5 66.6 5.1 0.3 0.0 27.8 0.3
Rhode Island 63 62 98.4 66.1 6.5 0.0 0.0 27.4 0.0
South Carolina 286 263 92.0 60.5 1.5 0.0 0.8 37.3 0.0
South Dakota 23 23 100.0 87.0 4.3 0.0 0.0 8.7 0.0
Tennessee 439 403 91.8 66.7 2.5 0.5 0.5 29.8 0.0
Texas 1,820 1,748 96.0 59.8 2.4 0.1 1.0 36.0 0.7
Utah 52 51 98.1 58.8 2.0 0.0 0.0 39.2 0.0
Vermont 5 4 80.0 25.0 0.0 0.0 0.0 75.0 0.0
Virginia 339 339 100.0 27.1 3.5 0.0 0.3 68.7 0.3
Washington 265 236 89.1 23.3 2.5 0.0 5.5 68.2 0.4
West Virginia 42 41 97.6 68.3 4.9 0.0 0.0 26.8 0.0
Wisconsin 109 109 100.0 51.4 2.8 0.0 0.0 45.9 0.0
Wyoming 4 4 100.0 50.0 0.0 0.0 0.0 50.0 0.0
American Samoa(d)
Fed. States of Micronesia(d)
Guam(d) 89 66 74.2 — - — — -
N. Mariana Islands(d)
Puerto Rico(d) 201 199 99.0 83.4 1.0 0.0 0.5 15.1 o.o
Republic of Palau(d) 
U.S. Virgin Islands(d)
(a) Occupation within past 24 months. Percentages shown only for reporting areas with information reported for >75% of cases.
(b) Percentage based on data from 51 areas reporting information on occupation for >75% of cases.
{c)Excludes New York City.
(d)Not included in totals.
Ellipses indicate data not available.
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Table 24. Tuberculosis Cases by Type of Health Care Provider: 59 Reporting Areas, 1996
Percent of Cases by Type of Health Care Provider(a) 
Cases Cases with Information on ..........  Both
Reporting Area
Total
Cases
Alive at 
Diagnosis
Type of Health Care Provider 
No. %
Health
Department Private/Other
Health Department 
and Private/Other
United States 21,221 20,443 20,007 97.9 45.5 (b) 27.5 (b) 27.0 (b)
Alabama 423 406 405 99.8 61.5 4.4 34.1
Alaska 97 97 97 100.0 70.1 14.4 15.5
Anzona 282 269 265 98.5 50.6 36.': 13.2
Arkansas 225 210 203 96.7 63.1 5.9 31.0
California 4,288 4,175 4,161. 99.7 49.2 34.8 16.0
Colorado 101 96 92 95.8 65.2 26.1 8.7
Connecticut 138 131 131 100.0 14.5 70.2 15.3
Delaware 43 43 43 100.0 58.1 7.0 34.9
District of Columbia 139 127 117 92.1 56.4 36.8 6.8
Florida 1,411 1,341 1,336 99.6 43.3 20.1 36.5
Georgia 791 767 742 96.7 39.6 17.3 43.1
Hawaii 200 195 195 100.0 41.0 23.1 35.9
Idaho 15 15 6 40.0 -- — -
Illinois 1,061 1,024 1,021 99.7 39.7 45.7 14.6
Indiana 202 192 192 100.0 24.0 17.2 58.9
Iowa 70 69 68 98.6 36.8 23.5 39.7
Kansas 73 71 68 95.8 39.7 23.5 36.8
Kentucky 259 244 232 95.1 47.4 11.2 41.4
Louisiana 420 406 367 90.4 55.6 16.3 28.1
Maine 21 20 20 100.0 45.0 0.0 55,0
Maryland 319 307 306 99.7 62.1 21.9 16.0
Massachusetts 262 258 256 99.2 57.4 16.0 26.6
Michigan 44? 424 424 100.0 65.6 32.8 1.7
Minnesota 131 130 130 100.0 53.6 43.1 3.1
Mississippi 250 239 239 100.0 1.7 0.8 97.5
Missoun 224 214 209 97.7 23.0 23.4 53.6
Montana 19 19 19 100.0 42.1 21.1 36.8
Nebraska 22 20 20 100.0 0.0 05.0 15.0
Nevada 137 126 119 94.4 70.6 16.0 13.4
New Hampshire 21 21 21 100.0 0.0 14.3 85.7
New Jersey 820 784 765 97.6 51.2 46.3 2.5
New Mexico 89 85 85 100.0 34.1 8.2 57.6
New York State(c) 532 522 504 96.6 41.3 38.3 20.4
New York City 2,017 1,928 1,922 99.7 32.2 22.6 45,3
Norlh Carolina 554 522 519 99.4 36.0 11.4 52.6
North Dakota 8 7 7 100.0 0.0 28.6 71.4
Ohio 301 290 284 97.9 36.6 384 25.0
Oklahoma 201 188 186 98.9 93.0 3.8 3.2
Oregon 189 184 178 96.7 39.3 23.6 37.1
Pennsylvania 580 553 516 93.3 38.2 43.0 18.8
Rhode Island 35 35 25 71.4 - — —
South Carolina 348 335 326 97.3 81.6 4.3 14.1
South Dakota 19 19 19 100.0 68.4 0.0 31.6
Tennessee 504 483 457 94.6 27.1 9,4 63.5
Texas 2,067 2,007 1,876 93.5 51.5 29.5 19.0
Utah 58 57 56 98.2 57.1 7.1 35.7
Vermont 4 4 4 100.0 0.0 0.0 100.0
Virginia 348 340 340 100.0 44.7 45.0 10.3
Washington 283 279 271 97.1 48.3 20.3 31.4
West Virginia 57 52 50 96.2 16.0 52.0 32.0
Wisconsin 114 106 106 100.0 9.4 11.3 79.2
Wyoming 7 7 7 100.0 0.0 42.9 57.1
American Samoa(d) ... 
Fed. States of Micronesia(d) ... 
Guam(d) ... 
N. Mariana Isiands(d) ... 
Puerto Rico(d) 222 207 203 98.1 91.1 8.4 0.5
Republic of Palau(d) 
U.S. Virgin Islands(d)
(a) Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact 
investigation and dispensing of medication} provided by non-health department providers; Both Health Department and Private/Other: Both 
sectors involved in care of patient. Percentages shown only for reporting areas with information reported for >75% of cases.
(b) Percentage based on data from 50 areas reporting information on type of health care provider for >75% of cases.
(c) Exdudes New York City.
(d) Not included in totals.
Ellipses indicate data not available.
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Table 25. Tuberculosis Cases by Directly Observed Therapy: 59 Reporting Areas, 1996
Reporting Area
Total
Cases
Cases with initial 
Drug Regimen 
Prescribed(a)
Cases with Information on 
Directly Observed Therapv
No. V,
Percent of Cases by 
Administration of Therapy(b) 
DOT Both DOT ana 
Only Self-Administered
United States 21,221 20,281 19,640 96.8 42.4 (c) 22.4 (c)
Alabama 423 404 403 99.8 84.1 10.4
Alaska 97 96 96 100.0 83.3 15.6
Arizona 282 265 259 97.7 46.3 12.7
Arkansas 225 208 203 97.6 29.6 15.3
California 4,288 4,137 4,009 96.9 38.1 16.6
Colorado 101 94 88 93.6 64.8 23.9
Connecticut 138 131 131 100.0 48.9 0.8
Delaware 43 43 41 95.3 41.5 41.5
District of Columbia 139 117 112 95.7 34.8 18.8
Florida 1 411 1,335 1,294 96.9 47.2 30.6
Georgia 791 766 712 93.0 53.8 24.2
Hawaii 200 195 195 100.0 54.9 9.7
Idaho 15 15 6 40.0 — »
Illinois 1,061 1,004 995 99.1 47.0 11.3
Indiana 202 192 192 100.0 42.7 7.8
Iowa 70 69 67 97.1 35.8 13.4
Kansas 73 70 66 94.3 47.0 28.8
Kentucky 259 243 232 95.5 45.3 24.6
Louisiana 420 393 357 90.8 68.6 19.6
Maine 21 20 20 100.0 20.0 10.0
Maryland 319 305 305 100.0 84.9 4.6
Massachusetts 262 258 256 99.2 30.1 14.1
Michigan 442 417 416 99.8 5.5 4.1
Minnesota 131 128 110 85.9 43.6 20.9
Mississippi 250 239 239 100.0 99.2 0.8
MiSSoun 224 214 207 96.7 54.6 17.4
Montana 19 19 18 94.7 33.3 22.2
Nebraska 22 20 20 100.0 10.0 20.0
Nevada 137 126 115 91.3 24.3 18.3
New Hampshire 21 21 21 100.0 9.5 33.3
New Jersey 820 781 753 96.4 10.6 32.7
New Mexico 89 84 83 98.8 30.1 18.1
New York Stateld) 532 522 520 99.6 56.7 22.9
New York City 2,017 1,911 1,905 99.7 0.2 63.5
North Carolina 554 521 519 99.6 54.5 21.8
North Dakota 8 7 7 100.0 57.1 42.9
Ohio 301 290 287 99.0 47.7 17.4
Oklahoma 201 187 186 99.5 55.4 1.1
Oregon 189 183 183 100.0 41.5 18.0
Pennsylvania 580 553 516 93.3 41.1 12.4
Rhode Island 35 35 25 71.4 --
South Carolina 348 335 325 97.0 77.2 7.7
South Dakota 19 19 19 100.0 63.2 21.1
Tennessee 504 483 453 93.8 27.4 24.5
Texas 2,067 1,989 1,860 93.5 61.6 24.2
Utah 58 55 54 98.2 55.6 18.5
Vermont 4 4 4 100.0 25-0 75.0
Virginia 348 334 334 100.0 50.9 1.8
Washington 283 279 265 95.0 58.9 10.2
West Virginia 57 52 45 86.5 13.3 13.3
Wisconsin 114 106 105 99.1 31.4 10.5
Wyoming 7 7 7 100.0 0.0 42.9
American Samoa(e) ... 
Fed. States of Micronesia(e) ... 
Guam(e) ... 
N. Manana Islands(e) ... 
Puerto Rico(e) 222 
Republic of Palau(e) ... 
U.S. Virgin Islands(e) ...
207 201 97.1 35.8 0.0
(a) lncludes patients alive at diagnosis with initial drug regimen of one or more drugs prescribed.
(b) Percentages shown only for reporting areas with information reported for >75% of cases.
(c) Percentage based on data from 50 areas reporting information on directly observed therapy for >75% of cases.
(d) Excludes New York City.
(e) Not included in totals.
Ellipses indicate data not availabfe.
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Table 26. Completion of Tuberculosis Therapy (COT): 59 Reporting Areas, 1996
Total Therapy <1 Year Indicated(a)_____  Therapy >1 Year Indicated(b) ______Overall
Reporting Area Cases No.(c) COT <1 Year(%) COT(%) No.(c) COT(%) No.(c) COT(%)
United States 21,221 17,985 75.1 (d) 69.5 (d) 330 68.7 (d) 18,315 89.1 (d)
Alabama ■'23 357 80 4 92 7 2 50.0 359 92 5
Alaska 97 93 96 8 98.9 0 93 98 9
Anzona 282 228 72 4 82 0 13 53.8 241 80 5
Arkansas 225 189 89 4 93.1 1 100.0 190 93 2
California 4,288 3,729 75 6 90.3 78 75.6 3,807 90 0
Colorado 101 84 82.1 86.9 0 84 86.9
Connecticut 138 119 69.7 92.4 1 100.0 120 92 5
Delaware 43 36 72.2 91.7 0 36 91 7
District of Columbia 139 95 63.2 82.1 4 75.0 99 81 8
Flonda 1,411 1,157 78 5 92.1 16 87.5 1,173 92 1
Georgia 791 697 76.2 89.4 9 66.7 706 89 1
Hawaii ?00 182 78 6 87 9 3 1000 185 881
Idaho 15 14 - - 1 - 15 -
Illinois 1,081 879 71 3 85 7 23 73 9 902 85.4
Indiana 202 176 75 6 88.1 0 176 88 1
Iowa 70 63 66.7 79.4 2 50.0 65 78 5
Kansas 73 66 69.7 83.3 1 100 0 67 83 6
Kentucky 269 210 77.6 87.6 6 83 3 216 87 5
Louisiana 420 358 74.3 84.9 1 100.0 359 85.0
Maine 21 19 78.9 94.7 0 19 94.7
Maryland 319 265 85.7 92.8 0 265 92.8
Massachusetts 262 247 76.9 93.9 1 100.0 248 94.0
Michigan 442 376 65.7 80.1 11 81.8 387 80.1
Minnesota 131 121 61.2 83.5 1 100.0 122 83.6
Mississippi 250 202 86.6 97.0 2 100.0 204 97.1
Missouri 224 192 78 6 91.1 1 100.0 193 91 2
Montana 19 16 87.5 93.8 1 100.0 17 94 1
Nebraska 22 18 77 8 83 3 0 18 83 3
Nevada 137 113 67.3 83.2 1 0.0 114 82 5
New Hampshire ?1 19 89 5 94.7 0 19 94 7
New Jersey 820 690 64.8 89.0 14 71.4 704 08 6
New Mexico 89 71 71.8 90.1 3 100.0 74 90 5
New York State(e) 532 455 70.8 91.2 9 66.7 464 90 7
New York City 2,017 1,624 72.8 92.2 56 53.6 1,680 91 0
North Carolina 554 470 84.3 95.1 3 100.0 473 951
North Dakota 8 5 1000 100.0 0 5 100 0
Ohio 301 239 80 3 92.9 1 100.0 240 92.9
Oklahoma 201 166 681 89.2 0 166 89 2
Oregon 189 170 76.5 84.1 1 0.0 171 83 6
Pennsylvania 580 476 74.8 87.4 1 0.0 477 87 2
Rhode Island 35 32 - - 0 32 „
South Carolina 348 304 63.5 89.8 3 100.0 307 89 9
South Dakota I9 18 88.9 94.4 0 18 94 4
Tennessee 504 417 78.7 89.7 3 66 7 420 89 5
Texas 2,067 1,786 74.8 87.2 44 54 5 1,830 86 4
Utah 58 51 76.5 92.2 1 100.0 52 92 3
Vermont 4 3 - - 0 3 -
Virginia 348 295 78.3 84.4 2 50.0 297 84 2
Washington 383 252 76.2 87.3 7 57.1 259 86.5
West Virginia 57 42 61.9 76.2 0 42 76.2
Wisconsin 114 92 84.8 95.7 3 100 0 95 95.8
Wyoming 7 7 71.4 85.7 0 7 85.7
American Samoa(f) ... ... ... ... ... . .  ... ...
Fed. States of Mlcronesia(f) ... ... ... ... ... . .  . .  ...
Guam(f) ... ... ... ... ... . .  ... ..
N Mariana Islands(f) ... ... ... ... .. . .  ... ..
Puerto RiCO(f) 222 168 79.2 89.3 7 57.1 175 88 0
Republic of Palau(f) .. .. .. . .. ... ... ...
U.S. Virgin lslands(f) ., ... ... ... ... ... . .  ..
(a) lmtial isolate susceptible to nfampin (n=13,505) or susceptibility unknown (n=602); culture-negative (n=2,880), culture status unknown (n=993); 
age unknown (n=5).
(b) lmtial isolate nfampin resistant, or pediatnc (age <15) case with meningeal, bone or joint, or miliary disease
(c) Number of cases in persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy Percentages 
only shown for reporting areas with information on reason therapy stopped for >90% of cases.
(d) Percentages based on data from 49 areas reporting information on reason therapy stopped for >90% of cases.
(e) Excludes New York City.
(f) Not included in totals.
Ellipses indicate data not available.
Note: See Technical Notes for descnption of COT calculation
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1 Table 27, Tuberculosis Cases in Selected Cities: 1998 and 1997
City —
Cases(a)
1§§7
Albuquerque, NM 16 16
Anaheim, Calif 48 46
Arlington, Tex 21 15
Atlanta, Ga 129 165
Austin, Tex 64 72
Baltimore, Md 84 92
Birmingham, Ala 65 50
Boston, Mass 89 79
Buffalo, NY 16 25
Charlotte, NC 55 80
Chicago, III 473 599
Cincinnati, Gnio 14 18
Cleveland, Ohio 45 86
Colorado Springs, Colo 4 6
Columbus, Ohio 40 16
Corpus Christ), Tex 35 43
Dallas, Tex 199 233
Denver, Colo 33 38
Detroit, Mich 142 171
El Paso, Tex 74 74
Fort Worth, Tex 86 71
Fresno, Calif 87 70
Honolulu, Hawaii 77 78
Houston, Tex 424 572
Indianapolis, Ind 41 34
Jacksonville, Fla 101 118
Kansas City, Mo 40 39
Las Vegas, Nev 92 64
Long Beach, Calif 57 100
Los Angeles, Calif 544 558
Louisville, Ky 35 26
Memphis, Tenn 109 120
Mesa, Arlz 10 16
Miami, Fla 101 111
Milwaukee, Wis 38 41
Minneapolis, Minn ' 63 67
Nashville, Tenn 70 61
New Orleans, La 84 98
New York, NY 1,558 1,730
Newark, N„ 90 108
Norfolk, Va 16 25
Oakland, Ci if 99 97
Oklahoma Cty, Okla 43 59
Omaha, Neb 12 10
Philadelphia, Pa 179 236
Phoenix, Ariz 93 107
Pittsburgh, Pa 26 21
Portland, Ore 70 72
Sacramento, Calif 92 109
St. Louis, Mo 61 60
St. Paul, Minn 22 28
San Antonio, Tex 87 95
San Diego, Calif 194 193
San Francisco, Calif 207 241
San Jose, Calif 180 174
Santa Ana, Calif 57 85
Seattle, Wash 84 81
Tampa, Fla 66 78
Toledo, Ohio 7 11
Tucson, Arlz 42 30
Tulsa, Okla 27 24
Virginia Beach, Va 8 15
Washington. DC 107 110
Wichita, Kan 20 37
Total -  64 Cities 7,152 8,024
San Juan, Puerto Rico 36 12
(a)Case counts are based on verified cases residing within city limits. Residence within city 
limits was determined by the health department.
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Table 28. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical
Areas with >500,000 Population, 1998 and 1997
Metropolitan 
Statistical Area
Cases Case Rate
Population
Estimates
19981666 1997 1 9 5 5 1997
Akron, Ohio 7 5 1.0 0.7 688,952
Albany-Schenectady, NY 14 22 1.6 2.5 871,604
Albuquerque, NM 25 24 3.7 3.6 678,633
Allentown, Pa 22 15 3.6 2.4 616,877
Ann Arbor, Mich 4 8 0.7 1.5 547,646
Atlanta, Ga 334 388 8.9 10.7 3,746,059
Austin, Tex 92 80 8.3 7.5 1,105,909
Bakersfield, Calif 46 63 7.6 10.0 63 f,459
Baltimore, Md 160 167 6.4 6.7 2,483,952
Baton Rouge, La 27 32 4.7 5.6 575,129
Bergen-Passaic, NJ 117 128 8.7 9.6 1,344,266
Birmingham, Ala 89 77 9.8 8.6 908,508
Boston, Mass 274 262 4.7 4.5 5,867,187
Buffalo, NY 35 45 3.0 3.9 1,152,541
Charleston, SC 37 47 6.8 9.2 541,159
Charlotte, NC 107 120 7.7 8.9 1,3B3,080
Chicago, III 730 858 9.2 11.0 7,939,351
Cincinnati, Ohio 30 43 1.9 2.7 1,617,836
Cleveland, Ohio 77 139 3.5 6.2 2,222,731
Columbia, SC 25 34 4.9 6.7 512,316
Columbus, Ohio 47 25 3.2 1.7 1,469,604
Dallas, Tex 291 312 9.1 10.0 3,209,886
Dayton, Ohio 17 15 1.8 1.6 948,522
Denver, Colo 54 62 2.8 3.3 1,938,642
Detroit, Mich 261 259 5.8 5.8 4,473,853
El Paso, Tex 81 76 11.5 10.8 703,127
Fort Lauderdale, Fla 135 124 9.0 8.4 1,503,407
Fort Worth, Tex 117 110 7.3 7.1 1,592,577
Fresno, Calif 121 102 13.9 11.7 870,478
Gary, Ind 23 19 3.7 3.0 624,049
Grand Rapids, Mich 32 34 3.1 3.3 1,037,933
Greensboro, NC 65 52 5.6 4.5 1,167,629
Greenville, SC 36 44 3.9 4.9 918,351
Harrisburg, Pa 25 17 4.1 2.8 616,031
Hartford, Conn 47 43 4.2 3.9 1,110,065
Honolulu, Hawaii 149 128 17.1 14.7 872,478
Houston, Tex 482 667 12.3 17.3 3,931,688
Indianapolis, Ind 56 50 3.7 3.3 1,519,194
Jacksonville, Fla 117 142 11.2 13.7 1,044,684
Jersey City, NJ 88 110 15.8 19.9 557,159
Kansas City, Mo 62 57 3.6 3.3 1,737,025
Knoxville, Tenn 45 47 6.8 7.2 659,074
Las Vegas, Nev 109 96 8.2 7.8 1,321,546
Little Rock, Ark 20 37 3.6 6.7 556,295
Los Angeles, Calif 1,372 1,458 14.9 15.9 9,213,533
Louisville, Ky 51 38 5.1 3.8 999,267
McAllen, Tex 80 78 15.3 15.3 522,204
Memphis, Tenn 131 140 12.0 12.9 1,093,427
Miami, Fla 288 317 13.4 15.5 2,152,437
Middlesex, NJ 94 90 8.4 8.1 1,121,504
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Table 28.(Cont'd) Tuberculosis Cases and Case Rates per 100,000 Population; Metropolitan
Statistical Areas with >500,000 Population, 1998 and 1997
Metropolitan 
Statistical Area
Cases Case Rate
Population
Estimates
1998“ T550-------------- 1997 ------ ------- 1357^
Milwaukee, Wis 54 49 3.7 3.4 1,459,805
Minneapolis-St. Paul, Minn 124 133 4.4 4.8 2,831,234
Mobile, Ala 43 41 8.1 7.8 532,257
Monmouth-Ocean City, NJ 40 33 3.7 3.1 1,093,253
Nashville, Term 97 116 8.4 10.2 1,156,225
Nassau-Suffolk, NY 154 157 5.8 5.9 2,673,489
New Haven, Conn 76 72 4.7 4.4 1,631,866
New Orleans, La 149 162 11.4 12.4 1,309,445
New York, NY 1,657 1,856 19.1 21.6 8,692,782
Newark, NJ 209 257 10.7 13.2 1,952,407
Norfolk, Va 65 84 4.2 5.4 1,542,143
Oakland, Calif 332 318 14.3 14.0 2,318,522
Oklahoma City, Okla 77 81 7.4 7.9 1,038,999
Omaha, Neb 20 13 2.9 1.9 693,900
Orange County, Calif 298 330 10.9 12.3 2,721,701
Orlando, Fla 163 171 10.8 11.7 1,504,569
Philadelphia, Pa 286 329 5.8 6.7 4,946,562
Phoenix, Ariz 145 183 4.9 6.4 2,931,004
Pittsburgh, Pa 52 71 2.2 3.0 2,346,153
Portland, Ore 118 118 6.5 6.6 1,818,955
Providence, Rl 61 36 6.7 4.0 905,612
Raleigh-Durham, NC 82 70 7.6 6.7 1,079,873
Richmond, Va 37 24 3.9 2.5 957,032
Riverside-San Bernardino, Calif 175 197 5.6 6.4 3,114,072
Rochester, NY 44 60 4.1 5.5 1,081,883
Sacramento, Calif 120 152 7.8 10.1 1,531,963
St. Louis, Mo 110 144 4.3 5.6 2,563,801
Salt Lake City, Utah 42 21 3.3 1.7 1,267,745
San Antonio, Tex 98 108 6.4 7.1 1,538,338
San Diego, Calif 339 333 12.2 12.2 2,780,592
San Francisco, Calif 307 338 18.2 20.3 1,683,309
San Jose, Calif 251 258 15.3 16.0 1,641,215
Sarasota, Fla 35 24 6.4 4.5 543,082
Scranton, Pa 14 27 2.3 4.3 615,491
Seattle, Wash 136 143 5.9 6.3 2,312,978
Springfield, Mass 12 17 2.0 2.9 588,993
Stockton, Calif 65 64 11.8 11.8 550,445
Syracuse, NY 23 28 3.1 3.8 734,640
Tacoma, Wash 36 43 5.3 6.5 676,505
Tampa-St. Petersburg, Fla 152 164 6.7 7.4 2,256,559
Toledo, Ohio 8 12 1.3 2.0 609,935
Tucson, Ariz 51 38 6.4 4.9 790,755
Tulsa, Okla 34 35 4.4 4.6 776,906
Ventura, Calif 57 79 7.8 10.9 731,967
Washington, DC 398 399 8.5 8.7 4,673,902
West Palm Beach, Fla 83 115 8.0 11.3 1,032,625
Wichita, Kan 22 39 4.0 7.4 544,343
Wilmington, Del 12 22 2.1 4.0 565,329
Youngstown, Ohio 17 13 2.9 2.2 591,752
Total -9 9  Areas 13,730 14,885 8.1 8.9 168,857,777
San Juan, Puerto Rico 79 138 3.9 6.9 2,007,980
43
Table 29. Tuberculosis Cases by Form of Disease: Metropolitan Statistical Areas with >500,000
Population, 1998
Metropolitan 
Statistical Area
Total
Cases
Puimonarv(a) Extrapulmonary(b)
Cases with Both Pulmonary 
and Extrapulmonary Disease 
Totalfc) Miliary
No. % No. % ^ o . ----------%-------------- N o------
Akron, Ohio 7 5 71.4 2 28.6 0 0.0 0
Albany-Schenectady, NY 14 10 71.4 3 21.4 1 7.1 0
Albuquerque, NM 25 13 52.0 8 32.0 4 16.0 1
Allentown, Pa 22 14 63.6 7 31.8 1 4.5 1
Ann Arbor, Mich 4 3 75.0 1 25.0 0 0.0 0
Atlanta, Ga 334 252 75.4 64 19.2 18 5.4 6
Austin, Tex 92 65 70.7 18 19.6 9 9.8 1
Bakersfield, Caitf 48 42 87.5 5 10.4 1 2.1 1
Baltimore, Md 160 99 61.9 38 23.7 23 14.4 10
Baton Rouge, La 27 22 81.5 5 18.5 0 0.0 0
Bergen-Passaic, NJ 117 75 64.1 34 29.1 8 6.8 4
Birmingham, Ala 89 60 67.4 22 24.7 7 7.9 0
Boston, Mass 274 157 57.3 97 35.4 20 7.3 7
Buffalo, NY 35 26 74.3 7 20.0 2 5.7 0
Charleston, SC 37 24 64.9 10 27.0 3 8.1 1
Charlotte, NC 107 83 77.6 19 17.8 5 4.7 0
Chicago, 1)1 730 566 77.5 133 18.2 31 4,2 6
Cincinnati, Ohio 30 24 80.0 6 20.0 0 0.0 0
Cleveland, Ohio 77 45 58.4 25 32.5 7 9.1 1
Columbia, SC 25 15 60.0 6 24.0 4 16.0 0
Columbus, Ohio 47 40 85.1 7 14.9 0 0.0 0
Dallas, Tex 291 204 70.1 60 20.6 27 9.3 5
Dayton, Ohio I7 14 82.4 3 17.6 0 0.0 0
Denver, Colo 54 33 61.1 11 20.4 10 18.5 4
Detroit, Mich 261 177 67.8 75 28.7 9 3.4 1
El Paso, Tex 81 58 71.6 13 16.0 10 12.3 0
Fort Lauderdale, Fla 135 114 84.4 19 14.1 2 1.5 1
Fort Worth, Tex 117 87 74.4 15 12.8 15 12.8 9
Fresno, Calif 121 92 76.0 19 15.7 10 8.3 0
Gary, Ind 23 21 91.3 2 8.7 0 0.0 0
Grand Rapids, Mich 32 19 59.4 10 31.3 3 9.4 0
Greensboro, NC 65 51 78.5 10 15.4 4 6.2 2
Greenville, SC 36 24 66.7 9 25.0 3 8.3 0
Harrisburg, Pa 25 16 64.0 9 36.0 0 0.0 0
Hartford, Conn 47 33 70.2 13 27.7 1 2.1 0
Honolulu, Hawaii 149 111 74.5 32 21.5 6 4.0 2
Houston, Tex 482 377 78.2 83 17.2 22 4.6 8
Indianapolis, Ind 56 35 62.5 20 35.7 1 1.8 1
Jacksonville, Fla 117 95 81.2 16 13.7 6 5.1 3
Jersey City, NJ 86 69 78.4 13 14.8 6 6.8 2
Kansas City, Mo 62 43 69.4 13 21.0 6 9.7 1
Knoxville, Tenn 45 37 82.2 3 6.7 5 11.1 1
Las Vegas, Nev 109 91 83.5 14 12.8 4 3.7 1
Little Rock, Ark 20 15 75.0 1 5.0 4 20.0 2
Los Angeles, Calif 1,372 991 72.2 263 19.2 118 8.6 41
Louisville, Ky 51 39 76.5 9 17.6 3 5.9 1
McAllen, Tex 80 63 78.8 12 15.0 5 6.3 1
Memphis, Tenn 131 77 58.8 34 26.0 20 15.3 2
Miami, Fla 2B8 246 85.4 31 10.8 11 3.8 9
Middlesex, NJ 94 52 55.3 32 34.0 10 10.6 0
(a) !ncludes cases with pulmonary listed as major site of disease and no additional site of disease.
(b) lncludes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major 
site of disease.
(c)lncludes miliary cases.
Note:5(<0.1%) cases had missing and/or unknown site of disease.
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Table 29.(Cont'd) Tuberculosis Cases by Form of Disease: Metropolitan Statistical Areas with
>500,000 Population, 1998
Metropolitan 
Statistical Area
Total
Cases
Pulmonary(a) Extrapul monary(b)
Cases with Both Pulmonary 
and Extrapulmonary Disease 
Totalfc) Miliarv
------- ----------— %— No. ---------g ----- No. % No.
Milwaukee, Wis 54 36 66.7 13 24.1 5 9.3 1
Mlnneapolis-St. Paul, Minn 124 70 56.5 47 37.9 7 5.6 2
Mobile, Ala 43 35 81.4 7 16.3 1 2.3 0
Monmouth-Ocean City, NJ 40 27 67.5 11 27.5 2 5.0 0
Nashville, Tenn 97 72 74.2 18 18.6 7 7.2 1
Nassau-Suffolk, NY 154 108 70.1 28 18.2 18 11.7 3
New Haven, Conn 76 48 63.2 23 30.3 5 6.6 3
New Orleans, La 149 127 85.2 17 11.4 5 3.4 3
New York, NY 1,657 1,126 68.0 315 19.0 215 13.0 57
Newark, NJ 209 137 65.6 41 19.6 31 14.8 12
Norfolk, Va 65 54 83.1 10 15.4 1 1.5 0
Oakland, Calif 332 251 75.6 58 17.5 23 6.9 6
Oklahoma City, Okla 77 61 79.2 12 15.6 4 5.2 0
Omaha, Neb 20 16 80.0 3 15.0 1 5.0 1
Orange County, Calif 298 197 66.1 72 24.2 29 9.7 9
Orlando, Fla 163 144 88.3 14 8.6 5 3.1 1
Philadelphia, Pa 266 188 65.7 74 25.9 24 8.4 4
Phoenix, Ariz 145 110 75.9 27 18.6 8 5.5 0
Pittsburgh, Pa 52 33 63.5 13 25.0 6 11.5 3
Portland, Ore 118 80 67.8 29 24.6 9 7.6 3
Providence, Rl 61 34 55.7 17 27.9 9 14.8 1
Raleigh-Duiham, NC 82 61 74.4 17 20.7 4 4.9 0
Richmond, Va 37 29 78.4 7 18.9 1 2.7 0
Riverside-San Bernardino, Calif 175 137 78.3 31 17.7 7 4.0 3
Rochester, NY 44 24 54.5 14 31.8 6 13.6 0
Sacramento, Calif 120 93 77.5 19 15.8 8 6.7 4
St. Louis, Mo 110 82 74.5 22 20.0 5 4.5 2
Salt Lake City, Utah 42 26 61.9 12 28.6 4 9.5 0
San Antonio, Tex 98 74 75.5 15 15.3 9 9.2 2
San Diego, Calif 339 243 71.7 68 20.1 28 8.3 8
San Francisco, Calif 307 227 73.9 65 21.2 15 4.9 2
San Jose, Calif 251 180 71.7 63 25.1 8 3.2 2
Sarasota, Fla 35 32 91.4 3 8.6 0 0.0 0
Scranton, Pa 14 11 78.6 3 21.4 0 0.0 0
Seattle, Wash 136 79 58.1 39 28.7 18 13.2 3
Springfield, Mass 12 9 75.0 2 16.7 1 8.3 1
Stockton, Calif 65 50 76.9 10 15.4 5 7.7 2
Syracuse, NY 23 13 56.5 7 30.4 3 13.0 1
Tacoma, Wash 36 29 80.6 7 19.4 0 0.0 0
Tampa-St. Petersburg, Fla 152 121 79.6 22 14.5 9 5.9 2
Toledo, Ohio 8 5 62.5 3 37.5 0 0.0 0
Tucson, Ariz 51 41 80.4 7 13.7 3 5.9 1
Tulsa, Okla 34 25 73.5 5 14.7 4 11.8 1
Ventura, Calif 57 51 89.5 3 5.3 3 5.3 3
Washington, DC 398 266 66.8 106 26.6 24 6.0 14
West Palm Beach, Fla 83 58 69.9 19 22.9 6 7.2 3
Wichita, Kan 22 16 72.7 5 22.7 1 4.5 1
Wilmington, Del 12 9 75.0 2 16.7 1 8.3 0
Youngstown, Ohio 17 11 64.7 6 35.3 0 0.0 0
Total - 99 Areas 13,730 9,880 72.0 2,792 20.3 1,053 7.7 301
San Juan, Puerto Rico 79 67 84.8 11 13.9 1 1.3 1
(a) lncludes cases with pulmonary listed as major site of disease and no additional site of disease.
(b) lncludes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, or other site, excluding pulmonary, listed as major 
site of disease.
(c)lncludes miliary cases.
Note: 5(<0.1%) cases had missing and/or unknown site of disease.
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Table 30. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000
Population, 1998
Metropolitan Total Unknown or
Statistical Area Cases Under 5 5 -  14 15 -24 2 5 -4 4 4 5 -6 4 65+ Missing
Akron, Ohio 7 0 0 0 2 1 4 0
Albany-Schenectady, NY 14 0 0 1 3 2 8 0
Albuquerque, NM 25 2 0 2 6 9 6 0
Allentown, Pa 22 0 0 1 5 6 10 0
Ann Arbor, Mich 4 0 0 0 2 1 1 0
Atlanta, Ga 334 24 14 23 140 97 36 0
Austin, Tex 92 5 2 12 36 23 14 ' 0
Bakersfield, Calif 48 2 1 3 14 13 15 0
Baltimore, Md 160 9 2 18 48 46 37 0
Baton Rouge, La 27 2 1 2 8 7 7 0
Bergen-Passaic, NJ 117 4 2 12 51 26 22 0
Birmingham, Ala 89 4 1 4 28 23 29 0
Boston, Mass 274 6 4 31 106 71 56 0
Buffalo, NY 35 0 0 2 10 6 17 0
Charleston, SC 37 2 2 4 6 12 11 0
Charlotte, NC 107 4 2 7 51 29 14 0
Chicago, III 730 36 26 59 287 207 115 0
Cincinnati, Ohio 30 0 0 0 7 9 14 0
Cleveland, Ohio 77 1 4 6 22 18 26 0
Columbia, SC 25 0 0 1 7 10 7 0
Columbus, Ohio 47 1 1 8 19 8 10 0
Dallas, Tex 291 5 8 25 145 79 29 0
Dayton, Ohio 17 0 0 1 2 1 13 0
Denver, Colo 54 3 3 2 19 11 16 0
Detroit, Mich 261 13 9 15 83 79 62 0
El Paso, Tex 81 3 0 4 19 28 27 0
Fort Lauderdale, Fla 135 4 4 4 67 30 26 0
Fort Worth, Tex 117 2 8 13 50 34 10 0
Fresno, Calif 121 12 4 12 33 42 18 0
Gary, Ind 23 0 1 0 6 7 9 0
Grand Rapids, Mich 32 1 0 3 15 8 5 0
Greensboro, NC 65 3 2 4 15 25 16 0
Greenville, SC 36 2 0 5 8 11 10 0
Harrisburg, Pa 25 2 0 2 10 8 3 0
Hartford, Conn 47 0 0 1 20 17 9 0
Honolulu, Hawaii 149 3 1 11 36 42 56 0
Houston, Tex 482 20 14 50 209 132 57 0
Indianapolis, ind 56 1 4 6 16 21 8 0
Jacksonville, Fla 117 3 1 5 52 39 17 0
Jersey City, NJ 88 4 5 9 40 23 7 0
Kansas City, Mo 62 1 0 4 19 19 19 0
Knoxville, Tenn 45 3 0 0 6 9 27 0
Las Vegas, Nev 109 6 3 10 40 33 17 0
Little Rock, Ark 20 0 0 0 5 4 11 0
Los Angeles, Calil 1,372 44 25 121 478 397 307 0
Louisville, Ky 51 4 0 0 14 18 15 0
McAllen, Tex 80 6 1 9 27 20 17 0
Memphis, Tenn 131 7 5 15 56 29 19 0
Miami, Fla 288 0 1 20 140 84 43 0
Middlesex, NJ 94 2 3 7 38 23 21 0
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Table 30.(Cont'd) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000
Population, 1998
Metropolitan 
Statistical Area
Total
Cases Under 5 5 - 1 4 15 -24 2 5 - 4 4 4 5 - 6 4 65+
Unknown or 
Missing
Milwaukee, Wis 54 0 1 2 20 16 15 0
Minneapolls-St. Paul, Minn 124 2 5 26 51 24 14 0
Mobile, Ala 43 0 2 3 12 18 8 0
Monmouth-Ocean City, NJ 40 1 1 4 14 7 13 0
Nashville, Tenn 97 1 1 9 33 27 26 0
Nassau-Suttolk, NY 154 5 3 25 49 33 39 0
New Haven, Conn 76 2 2 8 27 20 17 0
New Orleans, La 149 7 1 8 50 58 25 0
New York, NY 1,657 37 37 175 690 443 275 0
Newark, NJ 209 10 5 13 89 57 35 0
Norfolk, Va 65 4 2 5 16 14 24 0
Oakland, Cant 332 18 5 22 118 89 80 0
Oklahoma City, Okla 77 2 7 10 19 21 18 0
Omaha, Neb 20 0 0 0 7 9 4 0
Orange County, Calif 298 7 6 29 115 70 71 0
Orlando, Fla 163 2 0 12 78 48 23 0
Philadelphia, Pa 286 10 12 19 104 72 69 0
Phoenix, Anz 145 6 12 19 47 33 28 0
Pittsburgh, Pa 52 1 0 1 9 19 22 0
Portland, Ore 118 3 4 13 51 27 20 0
Providence, Rl 61 6 7 5 16 15 12 0
Haleigh-Durham, NC 82 4 1 6 23 21 27 0
Richmond, Va 37 0 0 1 16 10 10 0
Riverside-San Bernardino, Calif 175 8 4 21 53 49 40 0
Rochester, NY 44 0 2 4 14 7 17 0
Sacramento, Calif 120 4 2 6 32 39 37 0
St. Louis, Mo 110 5 0 3 34 33 35 0
Salt Lake City, Utah 42 0 1 1 21 11 8 0
San Antonio, Tex 98 2 3 6 26 30 31 0
San Diego, Calif 339 20 20 35 114 82 68 0
San Francisco, Calif 307 5 5 29 97 81 90 0
San Jose, Calif 251 4 3 28 99 62 55 0
Sarasota, Fla 35 0 0 2 10 16 7 0
Scranton, Pa 14 1 0 0 0 4 9 0
Seattle, Wash 136 3 2 15 52 35 29 0
Springfield, Mass 12 0 2 0 1 6 3 0
Stockton, Calif 65 3 1 4 18 25 14 0
Syracuse, NY 23 2 0 1 7 6 7 0
Tacoma, Wash 36 0 1 3 10 14 8 0
Tampa-St. Petersburg, Fla 152 6 4 8 55 52 27 0
Toledo, Ohio 8 0 0 0 1 3 4 0
Tucson, Anz 51 0 0 0 10 25 16 0
Tulsa, Okla 34 0 0 1 11 11 11 0
Ventura, Calif 57 4 2 7 14 15 15 0
Washington, DC 398 11 4 50 172 88 73 0
West Palm Beach, Fla 83 1 0 9 34 25 14 0
Wichita, Kan 22 2 0 2 9 3 6 0
Wilmington, Del 12 0 0 0 4 5 3 0
Youngstown, Ohio 17 0 1 0 3 3 10 0
Total - 99 Areas 13,730 465 335 1,206 5,081 3,778 2,865 0
San Juan, Puerto Rico 79 2 1 4 26 30 16 0
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Table 31. Tuberculosis Cases by Race/Ethnicity: Metropolitan Statistical Areas with >500,000 Population,
1998
American Indian Asian Unknown
Metropolitan Total White Black or or or
Statistical Area Cases Not Hispanic Not Hispanic Hispanic(a) Alaskan Native Pacific Islander Missing
Akron, Ohio 7 3 2 0 0 2 0
Albany-Schenectady, NY 14 9 2 0 0 3 0
Albuquerque, NM 25 6 1 10 5 3 0
Allentown, Pa 22 13 2 4 0 3 0
Ann Arbor, Mich 4 1 1 1 0 1 0
Atlanta, Ga 334 61 206 31 0 35 1
Austin, Tex 92 17 20 40 0 15 0
Bakersfield, Calif 48 12 5 20 1 10 0
Baltimore, Md 160 45 83 5 0 27 0
Baton Rouge, La 27 6 16 1 0 4 0
Bergen-Passaic, NJ 117 27 19 33 0 38 0
Birmingham, Ala 89 24 62 1 0 2 0
Boston, Mass 274 79 75 30 0 89 1
Buffalo, NY 35 18 9 0 0 8 0
Charleston, SC 37 6 29 1 0 1 0
Charlotte, NC 107 23 71 7 2 4 0
Chicago, III 730 126 348 123 2 130 1
Cincinnati, Ohio 30 18 7 0 0 5 0
Cleveland, Ohio 77 26 40 1 0 10 0
Columbia, SC 25 5 18 0 0 2 0
Columbus, Ohio 47 19 20 1 0 6 1
Dallas, Tex 291 45 119 89 2 31 5
Dayton, Ohio 17 11 5 0 0 1 0
Denver, Colo 54 11 10 20 0 13 0
Detroit, Mich 261 71 147 5 0 37 1
El Paso, Tex 81 6 2 71 0 2 0
Fort Lauderdale, Fla 135 35 76 16 0 8 0
Fort Worth, Tex 117 34 45 23 1 14 0
Fresno, Calif 121 11 8 73 0 29 0
Gary, Ind 23 6 13 3 0 1 0
Grand Rapids, Mich 32 9 5 12 0 6 0
Greensboro, NC 65 14 43 4 0 4 0
Greenville, SC 36 15 16 5 0 0 0
Harrisburg, Pa 25 9 8 4 0 4 0
Hartford, Conn 47 12 15 9 0 11 0
Honolulu, Hawaii 149 4 0 1 0 143 1
Houston, Tex 482 89 170 148 1 71 3
Indianapolis, Ind 56 24 17 9 0 5 1
Jacksonville, Fla 117 32 78 1 0 6 0
Jersey City, NJ 88 8 20 31 0 29 0
Kansas City, Mo 62 13 29 10 0 10 0
Knoxville, Tenn 45 40 4 0 0 1 0
Las Vegas, Nev 109 30 16 36 0 27 0
Little Rock, Ark 20 11 7 0 0 1 1
Los Angeles, Calif 1,372 146 182 587 7 450 0
Louisville, Ky 51 36 11 1 0 2 1
McAllen, Tex 80 1 0 76 0 3 0
Memphis, Tenn 131 19 103 1 0 8 0
Miami, Fla 288 21 155 103 0 6 3
Middlesex, NJ 94 25 9 20 0 40 0
(a)Persons of Hispanic origin may be of any race.
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Table 31.(Cont‘d) Tuberculosis Cases by Race/Ethnicity: Metropolitan Statistical Areas with >500,000
Population, 1998
Metropolitan 
Statistical Area
Total
Cases
White
Not Hispanic
Black
Not Hispanic Hispanic(a)
American Indian 
or
Alaskan Native
Asian
or
Pacific Islander
Unknown
or
Missing
Milwaukee, Wis 54 15 25 7 0 7 0
Minneapolis-St. Paul, Minn 124 13 58 4 8 40 1
Mobile, Ala 43 13 22 1 0 7 0
Monmouth-Ocean City, NJ 40 21 5 4 0 10 0
Nashville, Tenn 97 34 54 3 0 6 0
Nassau-Suffolk, NY 154 45 31 49 1 28 0
New Haven, Conn 76 21 30 14 0 11 0
New Orleans, La 149 28 98 8 0 14 1
New York, NY 1,657 181 668 467 0 341 0
Newark, NJ 209 28 113 51 0 17 0
Norfolk, Va 65 14 37 1 0 13 0
Oakland, Calif 332 31 83 37 2 179 0
Oklahoma City, Okla 77 43 5 10 10 9 0
Omaha, Neb 20 11 2 4 0 3 0
Orange County, Calif 298 28 1 106 0 161 2
Orlando, Fla 163 55 83 17 0 8 0
Philadelphia, Pa 286 60 140 28 0 57 1
Phoenix, Anz 145 41 13 72 6 13 0
Pittsburgh, Pa 52 30 19 1 0 2 0
Portland, Ore 118 44 13 17 1 43 0
Providence, Rl 61 18 7 19 0 17 0
Raleigh-Durham, NC 82 19 43 13 0 7 0
Richmond, Va 37 10 19 2 0 6 0
Riverside-San Bernardino, Calif 175 38 17 82 0 38 0
Rochester, NY 44 10 19 6 . 0 9 0
Sacramento, Calif 120 35 11 15 0 59 0
St. Louis, Mo 110 33 64 3 0 8 2
Salt Lake City, Utah 42 14 2 9 3 13 1
San Antonio, Tex 98 7 9 77 0 4 1
San Diego, Calif 339 44 16 169 2 108 0
San Francisco, Calif 307 52 25 43 3 184 0
San Jose, Calif 251 24 6 45 0 176 0
Sarasota, Fla 35 16 7 8 0 4 0
Scranton, Pa 14 13 0 0 0 1 0
Seattle, Wash 136 32 21 10 9 64 0
Springfield, Mass 12 6 1 2 0 3 0
Stockton, Calif 65 6 7 18 0 34 0
Syracuse, NY 23 10 10 3 0 0 0
Tacoma, Wash 36 16 4 2 1 13 0
Tampa-St. Petersburg, Fla 152 71 56 14 0 11 0
Toledo, Ohio 8 5 2 1 0 0 0
Tucson, Ariz 51 22 4 16 9 0 0
Tulsa, Okla 34 18 6 2 7 1 0
Ventura, Calif 57 10 1 28 0 18 0
Washington, DC 398 42 178 58 1 114 5
West Palm Beach, Fla 83 23 49 9 1 1 0
Wichita, Kan 22 4 2 7 0 9 0
Wilmington, Del 12 5 4 0 0 3 0
Youngstown, Ohio 17 7 6 2 0 2 0
Total - 69 Areas 13,730 2,696 4,445 3,231 85 3,237 34
San Juan, Puerto Rico 79 0 0 78 0 1 0
(a)Persons of Hispanic origin may be of any race.
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Table 32. Tuberculosis Cases, U.S.-Born Persons and Foreign-Bom Persons: Metropolitan
Statistical Areas with >500,000 Population, 1998
Metropolitan 
Statistical Area
Total
Cases
U.S.-born Persons Foreian-bom Personsfat Unknown
No. ---------- No. --------------- %------ N a---------
Akron, Ohio 7 5 71.4 2 28.6 0 0.0
Albany-Schenectady, NY 14 9 64.3 5 35.7 0 0.0
Albuquerque, NM 25 14 56.0 11 44.0 0 0.0
Allentown, Pa 22 13 59.1 9 40.9 0 0.0
Ann Arbor, Mich 4 4 100.0 0 0.0 0 0.0
Atlanta, Ga 334 247 74.0 85 25.4 2 0.6
Austin, Tex 92 58 63.0 34 37.0 0 0.0
Bakersfield, Calif 48 31 64.6 17 35.4 0 0.0
Baltimore, Md 160 117 73.1 43 26.9 0 0.0
Baton Rouge, La 27 21 77.8 6 22.2 0 0.0
Bergen-Passaic, NJ 117 42 35.9 75 64.1 0 0.0
Birmingham, Ala 89 85 95.5 4 4.5 0 0.0
Boston, Mass 274 87 31.8 186 67.9 1 0.4
Buffalo, NY 35 27 77.1 8 22.9 0 0.0
Charleston, SC 37 34 91.9 3 8.1 0 0.0
Charlotte, NC 107 96 89.7 11 10.3 0 0.0
Chicago, III 730 507 69.5 218 29.9 5 0.7
Cincinnati, Ohio 30 24 80.0 6 20.0 0 0.0
Cleveland, Ohio 77 55 71.4 22 28.6 0 0.0
Columbia, SC 25 23 92.0 2 8.0 0 0.0
Columbus, Ohio 47 34 72.3 13 27.7 0 0.0
Dallas, Tex 291 178 61.2 113 38.8 0 0.0
Dayton, Ohio 17 12 70.6 4 23.5 1 5.9
Denver, Colo 54 29 53.7 25 46.3 0 0.0
Detroit, Mich 261 199 76.2 61 23.4 1 0.4
El Paso, Tex 81 19 23.5 62 76.5 0 0.0
Fort Lauderdale, Fla 135 67 49.6 68 50.4 0 0.0
Fort Worth, Tex 117 78 66.7 38 32.5 1 0.9
Fresno, Calif 121 46 38.0 70 57.9 5 4.1
Gary, Ind 23 20 87.0 3 13.0 0 0.0
Grand Rapids, Mich 32 12 37.5 20 62.5 0 0.0
Greensboro, NC 65 53 81.5 12 18.5 0 0.0
Greenville, SC 36 32 88.9 4 11.1 0 0.0
Harrisburg, Pa 25 15 60.0 10 40.0 0 0.0
Hartford, Conn 47 24 51.1 23 48.9 0 0.0
Honolulu, Hawaii 149 41 27.5 107 71.8 1 0.7
Houston, Tex 482 301 62.4 179 37.1 2 0.4
Indianapolis, Ind 56 40 71.4 14 25.0 2 3.6
Jacksonville, Fla 117 111 94.9 6 5.1 0 0.0
Jersey City, NJ 86 30 34.1 58 65.9 0 0.0
Kansas City, Mo 62 43 69.4 19 30.6 0 0.0
Knoxville, Tenn 45 44 97.8 1 2.2 0 0.0
Las Vegas, Nev 109 58 53.2 50 45.9 1 0.9
Little Rock, Ark 20 16 90.0 1 5.0 1 5.0
Los Angeles, Calif 1,372 374 27.3 991 72.2 7 0.5
Louisville, Ky 51 47 92.2 4 7.8 0 0.0
McAllen, Tex 80 37 46.3 43 53.6 0 0.0
Memphis, Tenn 131 119 90.8 12 9.2 0 0.0
Miami, Fla 288 115 39.9 172 59.7 1 0.3
Middlesex, NJ 94 32 34.0 62 66.0 0 0.0
(a)Persons bom outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, 
U.S. Minor Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
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Table 32.(Cont'd) Tuberculosis Cases, U.S.-born Persons and Foreign-born Persons: Metropolitan
Statistical Areas with >500,000 Population, 1998
Metropolitan 
Statistical Area
Total
Cases
U.S.-born Persons Foreign-bom Persons(a) Unknown
----- F lo ---------- No. % -------
Milwaukee, Wis 54 41 75.9 13 24.1 0 0.0
Minneapolis-St. Paul, Minn 124 33 26.6 91 73.4 0 0.0
Mobile, Ala 43 37 66.0 6 14.0 0 0.0
Monmouth-Ocean City, NJ 40 23 57.5 17 42.5 0 0.0
Nashville, Tenn 97 77 79.4 19 19.^ 1 1.0
Nassau-Sulfolk, NY 154 63 40.9 90 58.4 1 0.6
New Haven, Conn 76 39 51.3 37 48.7 0 0.0
New Orleans, La 149 133 89.3 15 10.1 1 0.7
New York, NY 1,657 733 44.2 914 55.2 10 0.6
Newark, NJ 209 131 62.7 78 37.3 0 0.0
Norfolk, Va 65 48 73.8 16 24.6 1 1.5
Oakland, Calif 332 127 38.3 205 61.7 0 0.0
Oklahoma City, Okla 77 57 74.0 20 26.0 0 0.0
Omaha, Neb 20 9 45.0 11 55.0 0 0.0
Orange County, Calif 298 34 11.4 261 87.6 3 1.0
Orlando, Fla 163 129 79.1 33 20.2 1 0.6
Philadelphia, Pa 286 195 68.2 90 31.5 1 0.3
Phoenix, Ariz 145 75 51,7 70 48.3 0 0.0
Pittsburgh, Pa 52 47 90.4 5 9.6 0 0.0
Portland, Ore 118 52 44.1 66 55.9 0 0.0
Providence, Rl 61 26 42.6 35 57.4 0 0.0
Raleigh-Durham, NC 82 61 74.4 21 25.6 0 0.0
Richmond, Va 37 30 81.1 7 18.9 0 0.0
Riverside-San Bernardino, Calif 175 83 47.4 91 52.0 1 0.6
Rochester, NY 44 27 61.4 17 38.6 0 0.0
Sacramento, Calif 120 44 36.7 74 61.7 2 1.7
St. Louis, Mo 110 91 82.7 18 16.4 1 0.9
Salt Lake City, Utah 42 15 35.7 26 61.9 1 2.4
San Antonio, Tex 98 65 66.3 32 32.7 1 1.0
San Diego, Calif 339 112 33.0 226 66.7 1 0.3
San Francisco, Calif 307 80 26.1 227 73.9 0 0.0
San Jose, Calif 251 32 12.7 219 87.3 0 0.0
Sarasota, Fla 35 21 60.0 14 40.0 0 0.0
Scranton, Pa 14 13 92.9 1 7.1 0 0.0
Seattle, Wash 136 44 32.4 92 67.6 0 0.0
Springfield, Mass 12 8 66.7 4 33.3 0 0.0
Stockton, Calif 65 19 29.2 46 70.8 0 0.0
Syracuse, NY 23 18 78.3 5 21.7 0 0.0
Tacoma, Wash 36 22 61.1 14 38.9 0 0.0
Tampa-St. Petersburg, Fla 152 126 82.9 26 17.1 0 0.0
Toledo, Ohio 8 8 100.0 0 0.0 0 0.0
Tucson, Ariz 51 37 72.5 14 27.5 0 0.0
Tulsa, Okla 34 31 91.2 3 8.8 0 0.0
Ventura, Calif 57 21 36.8 36 63.2 0 0.0
Washington, DC 398 151 37.9 238 59.8 9 2.3
West Palm Beach, Fla 83 53 63.9 30 36.1 0 0.0
Wichita, Kan 22 7 31.8 15 68.2 0 0.0
Wilmington, Del 12 6 50.0 6 50.0 0 0.0
Youngstown, Ohio 17 14 82.4 3 17.6 0 0.0
Total - 99 Areas 13,730 7,075 51.5 6,589 48.0 66 0.5
(a)Persons bom outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the 
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, 
U.S. Minor Outlying Islands, U.S. Miscellaneous Pacific Islands, and the U.S. Virgin Islands.
*
*
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Figure 1. Tuberculosis Case Rates, United States, 1998
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Figure 2. Tuberculosis Cases and Deaths
United States, 1953 -1998
Year
*Change in reporting criteria.
Note: 1998 deaths are not available.
1
Figure 3. Tuberculosis Cases Reported by County
United States, 1998
O l
0 Cases 
1 - 9  Cases 
10 or More Cases 
Total Counties
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1,322 (42.1%) 
269 ( 8.6%) 
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Figure 4. Reported Tuberculosis Cases by Race/Ethnicity
United States, 1998
White, non-Hispanic 
4,495 (24.5%)
Unknown 
60 (0.3%)
Black, non-Hispanic 
5,831 (31.8%)
Hispanic* 
4,099 (22.3%)
Asian/Pacific Islander 
3,623(19.7%) American Indian/ Alaskan Native 
253(1.4%)
Persons of Hispanic origin may be of any race.
Figure 5. Reported Tuberculosis Cases by Country of Origin
United States, 1998
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All Others* 
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‘ Includes 149 countries.
Figure 6. Reported Tuberculosis Cases by Form of Disease
United States, 1998
Pleural 
736 (20.8%)
Lymphatic
Bone and/or Joint 
377 (10.6%) Genitourinary 
247 (7.0%)
158 (4.5%)
Meningeal 
177 (5.0%)
* Includes 378 miliary cases.
KFigure 7. Reported Tuberculosis Cases by Verification Criterion
United States, 1998
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Figure 8. Trends in TB Cases in U.S.-born Persons
United States*, 1986-1998
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Figure 9. Trends in TB Cases in Foreign-born Persons
United States*, 1986-1998
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Figure 10. Tuberculosis Case Rates by Origin
United States, 1986 -1998
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Figure 11. Isoniazid Resistance Among Cases without
Previous TB, United States, 1998
U.S. Total = 7.7%*
*  Percentage based on data from 46 areas reporting information on initial drug susceptibility results for >. 75% of cases.
Figure 12. Reported Tuberculosis Cases1 23by Administration of Therapy
United States, 1996
CD
CD
Unknown/Missing
(3.2%)
Totally Self-Administered 
(34.1%)
Directly Observed and 
Self-Admi ni stered 4 
(21.7%)
Totally , 
Directly Observed' 
(41.1%)
1 Patients alive at diagnosis with initial drug regimen of 1 or more drugs prescribed.
2 No doses of medication were given under supervision.
3 All doses of medication were given under supervision.
4One or more doses of medication were given under supervision and one or more doses were not.
Figure 13. Reported Tuberculosis Cases1 by Reason
Therapy Stopped, United States, 1996
Died (9.7%) 123
1 Patients alive at diagnosis with initial drug regimen of 1 or more drugs prescribed.
2 Patient moved to another jurisdiction with a known forwarding address before treatment was completed.
3 Patient could not be located prior to the completion of treatment.

Technical Notes
National Surveillance for Tuberculosis
All reporting areas (i.e., the 50 states, the District of Columbia, New York City, Puerto Rico, 
and other U.S. jurisdictions in the Pacific and Caribbean) report tuberculosis (TB) cases to CDC 
using a standard case report form, Report of a Verified Case of Tuberculosis (RVCT).1 Reported 
TB cases are verified according to the TB case definition for public health surveillance (MMWR 
1997;46[No. RR-10]:40-1). Cases may be verified using the laboratory or clinical case 
definition. A case may be verified by the laboratory case definition either by (1) isolation of M. 
tuberculosis from a clinical specimen, OR (2) demonstration of acid-fast bacilli (AFB) in a 
clinical specimen when a culture has not been or cannot be obtained. A case may be verified by 
the clinical case definition in the presence of ALL of the following clinical criteria: (a) a positive 
tuberculin skin test result, (b) other signs and symptoms compatible with TB, such as an 
abnormal, unstable (worsening or improving) chest radiograph, or clinical evidence of current 
disease, (c) treatment with two or more antituberculosis medications, and (d) a completed 
diagnostic evaluation. When patients are diagnosed with TB but do not meet the case definition 
(e.g., anergic patients with a clinical picture consistent with TB but without laboratory evidence 
of M. tuberculosis), reporting areas also have the option of verifying TB cases based on provider 
diagnosis.
In January 1993, in conjunction with state and local health departments, CDC implemented 
an expanded surveillance system for TB to collect additional data to better monitor and target 
groups at risk for TB disease, to estimate and follow the extent of drug-resistant TB, and to 
evaluate outcomes of TB cases. The RVCT form for reporting TB cases was revised to collect 
information on occupation, the initial drug regimen, human immunodeficiency virus (HIV) test 
results, history of substance abuse and homelessness, and residence in correctional or long-term 
care facilities at the time of diagnosis. RVCT Follow Up Report-1 was added to collect drug 
susceptibility results for the initial M. tuberculosis isolate from patients with culture-positive 
disease. To evaluate the outcomes of TB therapy, RVCT Follow Up Report-2 was added to 
collect information on the reason and date therapy was stopped, the type of health care provider, 
sputum culture conversion, the use of directly observed therapy, and the results of drug 
susceptibility testing for the final M. tuberculosis isolate from patients with culture-positive 
disease. Since 1993, RVCT data have been reported to CDC using software specifically 
developed for expanded TB surveillance (i.e., SURVS-TB, 1993-1997; TIMS, 1998).
Instructions for completing the RVCT forms and definitions for all data items were included in 
the software user’s guide. Summary data presented for 1998 TB cases in this publication (and 
for 1996 cases, Tables 24-26) were received at CDC via TIMS by June 3,1999.
‘Other U.S. jurisdictions include Guam, American Samoa, the Republic of the Marshall Islands, the Commonwealth of the Northern Mariana 
Islands, the Federated States of Micronesia, the Republic of Palau, and the U.S. Virgin Islands. RVCT data for 1998 were available only for 
Guam.
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Completion of Tuberculosis Therapy
Table 26 is a recent addition to this publication and presents rates of completion of TB 
therapy (COT) by reporting area. Data collected by RVCT Follow Up Report-2 on date and 
reason therapy stopped (e.g., patient completed therapy, moved, was lost) were used to calculate 
rates of COT. Cases were stratified by the indicated length of therapy based on current American 
Thoracic Society/CDC treatment guidelines2 and the patient’s initial drug susceptibility test 
results, age, and site of disease. The adequacy of the treatment regimen (e.g., the sufficiency of 
the duration of therapy, the appropriateness of the prescribed TB drugs) was not evaluated in this 
analysis. Acquired drug resistance during therapy with the need for a longer duration of therapy 
was also not considered in this analysis.
The first column shows the total number of cases reported during 1996. The remaining 
columns are grouped under three headings: therapy of 1 year or less indicated, therapy greater 
than 1 year indicated, and overall. Patients with an initial isolate resistant to rifampin and 
pediatric patients (age under 15 years old) with meningeal, bone or joint, or miliary disease were 
included under the category of greater than 1 year of therapy indicated. All other patients, 
including those with culture-negative disease, an unknown culture status, and those with 
culture-positive disease but unknown initial drug susceptibility test results, were included under 
the category of 1 year or less of therapy indicated.
Each group for an indicated length of therapy has an initial column showing the number of 
cases in persons who were alive at diagnosis and prescribed an initial regimen of one or more 
drugs, and who did not die during therapy. This number was used as the denominator in COT 
rate calculations. COT rates, shown as percentages, were only calculated for reporting areas that 
had information on reason therapy stopped for at least 90% of cases shown in the overall column. 
For the group with an indicated length of therapy 1 year or less, rates are shown for both 
completion of therapy in 1 year or less (COT <1 year) and for COT, regardless of duration of 
therapy (i.e., duration of therapy <1 year, >1 year, or unknown). For COT <1 year, the numerator 
included only those patients completing therapy in <365 days (based on the dates therapy started 
and stopped). Patients with missing dates were classified as “treatment not completed” for this 
calculation. Rates of COT, regardless of duration of therapy, were calculated by dividing the 
number of patients reported as having completed therapy by the number of patients listed in the 
first column of each group. Patients with an outcome other than completed therapy (i.e., moved, 
lost, refused treatment, and other) were classified as “treatment not completed.” Patients with an 
unknown outcome were also classified as “treatment not completed.” For the remaining two 
groups of indicated therapy length (greater than 1 year and overall), only rates of COT, regardless 
of duration of therapy, are presented.
Acknowledgment: Table 26 was developed in collaboration with the Field Services Branch, 
Division o f Tuberculosis Elimination, CDC.
^TS/CDC. Treatment of tuberculosis and tuberculosis infection in adults and children AmJRespir Crtt Care Med 1994;149:1359-74.
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Site of TB Disease
Tables 12, 13, and 29 and Figure 6 reflect a recent change in the definition of miliary disease 
used in this publication. Miliary disease is now classified as both an extrapulmonary and a 
pulmonary form of TB. In publications prior to 1997, miliary disease was classified as 
extrapulmonary TB unless pulmonary disease was reported as the major site of TB disease.
Reporting of HIV Infection
Table 22 shows information on HIV status for TB cases among persons aged 25-44 years, the 
age group in which 75% of AIDS cases occur (CDC. HIV/AIDS Surveillance Report 1998;10[No.
2]: 16). Information on HIV status for TB cases reported in 1998 is incomplete. Reasons for 
incomplete reporting of HIV test results to the national surveillance system include concerns about 
confidentiality, which may limit the exchange of data between TB and HIV/AIDS programs; laws 
and regulations in selected states and local jurisdictions that have been interpreted as prohibiting the 
HIV/AIDS program from sharing the HIV status of TB patients with the TB program, or from 
reporting patients with TB and AIDS to the TB program; and reluctance by health care providers to 
report HIV test results to the TB surveillance program staff. In addition, health care providers may 
not offer counseling and HIV testing to some TB patients because of a lack of resources or of 
appropriately trained staff, or due to the perception that selected patients (e.g., foreign-bom persons) 
are not at risk for HIV infection.
Data on the HIV infection status of reported TB patients in 1998 should be interpreted with 
caution. These data are not representative of all TB patients with HIV infection. HIV testing is 
performed after a patient receives counseling and gives informed consent. Since testing is 
voluntary, some TB patients may decline HIV testing. TB patients who are tested anonymously 
may choose not to share the results of HIV testing with their health care provider. TB patients 
managed in the private sector may receive confidential HIV testing, but results may not be reported 
to the TB program in the health department. In addition, many factors may influence HIV testing of 
TB patients, including the extent to which testing is targeted or routinely offered to specific groups 
(e.g., 25-44 year old males, injecting drug users, homeless persons), and the availability and access 
to HIV testing services. These data do not provide a minimum estimate of the number of TB 
patients known to be HIV infected in a reporting area.
Tabulation and Presentation of TB Data
This report primarily presents summary data for TB cases reported to CDC in 1998. Data from 
the RVCT Follow Up Report-2 (i.e., completion of therapy, the use of directly observed therapy, 
and the type of health care provider) are only presented for cases reported in 1996. TB cases are 
tabulated by the year in which the reporting area verified that the patient had TB and included the 
patient in its official annual TB case count. Totals for the U.S. only include data from the 50 states, 
the District of Columbia, and New York City. Age group tabulations are based on the patient’s age 
in the month and year the patient was reported to the health department as a suspected TB case.
State or metropolitan area data tabulations are based on the patient’s residence at diagnosis of TB 
(see Appendix: “Recommendations for Counting Reported Tuberculosis Cases”).
Tables 28 through 32 present data by metropolitan statistical areas (MS As) with an estimated 
1998 population of 500,000 or more. Metropolitan areas are defined by the federal Office of 
Management and Budge.', and the definitions effective as of June 30,1998, were used for this 
publication (www.census.gov/population/www.estimates/pastmetro.html). The metropolitan area 
definitions apply to all areas except the six New England states; for these states, the New England
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County Metropolitan Areas (NECMAs) are used. Metropolitan areas are named for a central city in 
the MSA or NECMA, may include several cities and counties, and may cross state boundaries. For 
example, the TB cases and case rates presented for the District of Columbia in Table 6 include only 
persons residing within the geographic boundaries of the District. However, the TB cases and case 
rates for Washington, D.C., (Table 28) include persons residing within the several counties in the 
metropolitan area, including counties in Maryland, Virginia, and West Virginia. The cities and 
counties that comprised each metropolitan area in 1998 are available from the National Technical 
Information Service (1-800-553-NTIS, accession no. PB98-502198, Metropolitan Areas for 1998).
Rates
Rates are expressed as the number of cases reported each calendar year per 100,000 population. 
Population denominators used in calculating TB rates (Table 6) are based on official postcensus 
estimates from the U.S. Census Bureau. The denominators for computing race-specific rates (Table 
3) are based on 1998 estimates from the Population Projections Branch, Population Division, U.S. 
Census Bureau. The denominators for computing rates for foreign-bom persons (Figure 10) are 
based on population estimates from the U.S. Census Bureau Current Population Report P20-507, 
The Foreign-Born Population in the United States: March 1997 (Update), previous reports in this 
series, and the decennial census years of 1980 and 1990.
Mortality Data
Official TB mortality statistics for the United States are compiled by the National Center for 
Health Statistics (NCHS), CDC. The annual mortality rate is calculated as the number of deaths 
due to TB in that year, divided by the estimated population for the year, multiplied by 100,000 
(Table 1 and Figure 2). The number of deaths for 1997 was obtained from the NCHS National 
Vital Statistics Report (Vol. 47, No. 19), June 30,1999. The number of deaths for 1998 was not 
available at the time of this publication.
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Tuberculosis Case Definition for Public Health Surveillance1
Tuberculosis (Revised 9/96)
Clinical description
A chronic bacterial infection caused by Mycobacterium tuberculosis, characterized 
pathologically by the formation of granulomas. The most common site of infection is the lung, 
but other organs may be involved.
Clinical case definition
A case that meets the following criteria:
•  A positive tuberculin skin test
•  Other signs and symptoms compatible with tuberculosis (e.g. an abnormal, unstable 
[i.e., worsening or improving] chest radiographs, or clinical evidence of current disease)
•  Treatment with two or more antituberculosis medications
•  Completed diagnostic evaluation
Laboratory criteria for diagnosis
•  Isolation of M. tuberculosis from a clinical specimen*  or
•  Demonstration of M. tuberculosis from a clinical specimen by nucleic acid 
amplification test*, or
•  Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or 
cannot be obtained.
Case classification
Confirmed: a case that meets the clinical case definition or is laboratory confirmed 
Comment
A case should not be counted twice within any consecutive 12-month period. However, cases in 
which the patients had previously had verified disease should be reported again if the patients 
were discharged from treatment. Cases also should be reported again if patients were lost to 
supervision for >12 months and disease can be verified again. Mycobacterial diseases other 
than those caused by M. tuberculosis complex should not be counted in tuberculosis morbidity 
statistics unless there is concurrent tuberculosis.
]CDC. Case definitions for infectious conditions under public health surveillance. MMWR
1997;46(No, RR-10):40-41.)
*Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic 
acids high-pressure liquid chromatography performed on a culture from a clinical specimen) 
are acceptable under this criterion.
^Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria 
species. However, for surveillance purposes, CDC will accept results obtained from NAA 
tests approved by the Food and Drug Administration (FDA) and used according to the 
approved product labeling on the package insert. Current FDA-approved NAA tests are only 
approved for smear-positive respiratory specimens.
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Recommendations for Counting Reported Tuberculosis Cases 
(Revised July 1997)
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in 
January 1977, numerous changes have occurred and many issues have been raised within the 
field of tuberculosis (TB) surveillance. This current version updates and supersedes the previous 
version; it clarifies the parameters for counting TB cases among (a) immigrants, resident aliens, 
and border crossers, (b) military personnel stationed in the United States and abroad, and (c) 
persons diagnosed within the Indian Health Service and correctional facilities.
A distinction should be made between reporting TB cases to a health department and counting 
TB cases for determining incidence of disease. Throughout each year, TB cases and suspected 
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories, 
and health care providers. From these reports, the state or local TB control officer must 
determine which cases meet the current surveillance definition for TB disease. These verified 
TB cases are then counted and reported to the Centers for Disease Control and Prevention 
(CDC).
I. Reporting TB Cases.—CDC recommends that health care providers and laboratories be 
required to report all TB cases or suspected cases to state and local health departments based on 
the current “Case Definition for Public Health Surveillance.”2 This notification is essential in 
order for TB programs to
•  Ensure case supervision
•  Ensure completion of appropriate therapy
•  Ensure completion of timely contact investigations
•  Evaluate program effectiveness
•  Assess trends and characteristics of TB morbidity
II. TB Surveillance.—For purposes of surveillance, a case of TB is defined on the basis of 
laboratory and/or clinical evidence of active disease due to M. tuberculosis complex.*
* Mycobacterium tuberculosis complex (M tuberculosis complex) consists of three 
mycobacterial species: M. tuberculosis, M. bovis, and M. africanum. These species are identical 
in DNA homology studies. In terms of their ability to cause clinical disease and be transmissible 
from person to person, M. bovis and M africanum behave like M. tuberculosis; therefore, 
disease caused by any of the three organisms should be reported as TB, using the Report of 
Verified Case of Tuberculosis (RVCT). The only exception is the BCG strain of M. bovis, which 
may be isolated from persons who have received the vaccine for protection against TB or as 
cancer immunotherapy; disease caused by this M. bovis strain should not be reported as TB 
because the transmission is iatrogenic (treatment-induced), rather than person-to-person or 
communicable.
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a. Laboratory Case Definition.
•  Isolation of M. tuberculosis complex from a clinical specimen. The use of rapid- 
identification techniques for M. tuberculosis performed on a culture fiom a clinical 
specimen, such as DNA probes and high-pressure liquid chromatography (HPLC), is 
acceptable under this criterion.
OR
•  Demonstration of M. tuberculosis from a clinical specimen bv nucleic acid 
amplification (NAA) test. NAA tests must be accompanied by cultures of 
mycobacterial species. However, for surveillance purposes, CDC will accept 
results obtained fiom NAA tests that are approved by the Food and Drug 
Administration (FDA) and used according to the approved product labeling on 
the package insert. Current FDA-approved NAA tests are only approved for use 
on smear-positive respiratory specimens.
OR
•  Demonstration of acid-fast bacilli (AFB1 in a clinical specimen when a culture has 
not been or cannot be obtained: historically this criterion has been most commonly 
used to diagnose TB in the postmortem setting.
b. Clinical Case Definition.—In the absence of laboratory confirmation of M. tuberculosis
complex after a diagnostic process has been completed, persons must have all of the following 
criteria for clinical TB:
•  Evidence of TB infection based on a positive tuberculin skin test
AND
•  One of the following:
(1) Signs and symptoms compatible with current TB disease, such as an abnormal, 
unstable (worsening or improving! chest radiograph, or
(2) Clinical evidence of current disease (e.g.. fever, night sweats, cough, weight 
loss, hemoptysis^
AND
•  Current treatment with two or more anti-TB medications
NOTE: The case definition described herein was developed for use in this document and is not 
intended to replace the case definition for TB as stated in the current “Case Definitions for 
Infectious Conditions Under Public Health Surveillance. ”
In addition, the software for TB surveillance developed by CDC includes a calculated variable
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called “ Vercrit, "for which one o f the values is “Provider Diagnosis. ” “Provider Diagnosis " 
is selected when the user chooses to override a “Suspect” default value in the case verification 
screen as “ Verified by Provider Diagnosis. " Thus, “Provider Diagnosis " is not a component 
of the case definition for TB in the current "Case Definitions for Infectious Conditions Under 
Public Health Surveillance ” publication. CDC’s national morbidity reports have traditionally 
included all cases that are considered verified by the reporting areas, without a requirement 
that cases meet the published case definition.
III. Counting TB Cases.—Cases that meet the current CDC surveillance case definition for
verified TB are counted by 52 reporting areas with count authority (50 states, District of 
Columbia, and New York City) to determine annual incidence for the United States. The 
remaining 7 reporting areas (American Samoa, Federated States of Micronesia, Guam,
Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands) report 
cases to the CDC but are not included in the annual incidence for the United States. Laboratory 
and clinical case definitions are the two primary diagnostic categories used by the CDC “Case 
Definitions for Infectious Conditions Under Public Health Surveillance.”
Most verified TB cases are accepted for counting based on laboratory confirmation of M. 
tuberculosis complex from a clinical specimen.
A person may have more than one discrete (separate and distinct) episode of TB, If disease 
recurs in a person within any 12-consecutive-month period, count only one episode as a case 
for that year. However, if TB disease recurs in a person, and if more than 12 months have 
elapsed since the person was discharged from or lost to supervision, the TB is considered a 
separate episode and should be counted as a new case.
Mycobacterial diseases other than those caused by M. tuberculosis complex should not be 
counted in TB morbidity statistics unless there is concurrent TB.
a. Verified TB Car.es.
COUNT
Count only verified TB cases that meet the laboratory or clinical case definitions (see 
Section II). The diagnosis of TB must be verified by the TB control officer or designee. 
The current CDC surveillance case definition for TB describes and defines the criteria 
to be used in the case definition for TB disease.
DO NOT COUNT
If diagnostic procedures have not been completed, do not count; wait for confirmation 
of disease. Do not count a case for which two or more anti-TB medications have been 
prescribed for preventive therapy for exposure to multidrug-resistant (MDR) TB, or 
while the diagnosis is still pending.
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b. Nontuberculous Mycobacterial Diseases (NTM).
COUNT
An episode of TB disease diagnosed concurrently with another nontuberculous 
mycobacterial disease should be counted as a TB case.
DO NOT COUNT
Disease attributed to or caused by nontuberculous mycobacteria alone should not be 
counted as a TB case.
c. TB Cases Reported at Death.
COUNT
TB cases first reported to the health department at the time of a person’s death are 
counted as incident cases provided that the person had current disease at the time of 
death. The TB control officer should verify the diagnosis of TB.
DO NOT COUNT
Do not count as a case of TB if there is no evidence of current disease at the time of 
death or at autopsy.
d. Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign 
Visitors.4
COUNT
Immigrants and refugees who have been screened overseas for TB and
•  have been classified as Class B (B1, B2, or B3)3 or resident aliens
•  are not already on anti-TB medications for treatment of tuberculous disease, and
•  are examined after arriving in the United States and diagnosed with clinically active 
TB requiring anti-TB medications
should be counted by the locality of their current residence at the time of diagnosis 
regardless of citizenship status.
Border crossers’*1 and permanent resident aliens who are diagnosed with TB and plan to 
receive anti-TB therapy from a locality in the United States for 90 days or more should 
be counted by the locality where they receive anti-TB therapy.
Foreign visitors (e.g., students, commercial representatives, and diplomatic personnel) 
who are diagnosed with TB, are receiving anti-TB therapy, and plan to remain in the 
United States for 90 days or more should be counted by the locality of current 
residence.
♦Border crosser - defined, in part, by the Immigration and Naturalization Service (INS)4 
as “a nonresident alien entering the United States across the Mexican border for stays of 
no more than 72 hours.” Border crossers may go back and forth across the border many 
times in a short period.
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DO NOT COUNT
TB cases in immigrants or refugees who have been classified as Class A with a waiver 
(TB, infectious, “Noncommunicable for travel purposes”)3 should not be counted as 
new cases even if the persons receive routine initial work-ups in the United States.
TB in persons who are temporarily (<90 days) in the United States, for whom therapy 
may have been started but who plan to return to their native country to continue therapy, 
should not be counted in the United States.
Out-of-State or Out-of-Area Residents.
COUNT
A person’s TB case should be counted by the locality in which he or she resides at the 
time of diagnosis TB in a person who has no address should be counted by the locality 
that diagnosed and is treating the TB. The TB control officer should notify the 
appropriate out-of-state or out-of-area TB control officer of the person’s home locality 
to (1) determine whether the case has already been counted to avoid “double counting,” 
and (2) agree on which TB control office should count the case if it has not yet been 
counted.
DO NOT COUNT
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident and 
whose TB has already been counted by the out-of-area TB control office.
Migrants and Other Transients.
COUNT
Persons without ;my fixed U.S. residence are considered to be the public health 
responsibility of their present locality and their TB case should be reported and counted 
where diagnosed.
DO NOT COUNT
Cases in transient TB patients should not be counted when there is evidence that they 
have already been counted by another locality.
Federal Facilities (e.g., Military and Veterans Administration Facilities).
COUNT
Cases in military personnel, dependents, or veterans should be reported and counted by 
the locality where the persons are residing in the United States at the time of diagnosis 
and initiation of treatment.
However, if military personnel or dependents are discovered to have TB at a military 
base outside the United States but are referred elsewhere for treatment (e.g., a military 
base located within the United States), the TB case should be reported and counted 
where treated and not where the diagnosis was made.
DO NOT COUNT
Do not count if the case was already counted by another locality in the United States.
h. Indian Health Service.
COUNT
TB should be reported to the local health authority (e.g., state or county) and counted 
where diagnosed and treatment initiated. However, for a specific group such as the 
Navajo Nation, which is geographically located in multiple states, health departments 
should discuss each case and determine which locality should count the case.
DO NOT COUNT
Do not count if the case was already counted by another locality.
i. Correctional Facilities (e.g., Local, State, Federal, and Military).
COUNT
Persons who reside in local, state, federal, or military correctional facilities may 
frequently be transferred or relocated within and/or between various correctional 
facilities. TB in these persons should be reported to the local health authority and 
counted by the locality where the diagnosis was made and treatment plans were 
initiated.
DO NOT COUNT
Do not count correctional facility residents’ TB cases that were counted elsewhere by 
another locality or correctional facility, even if treatment continues at another locale or 
correctional facility.
j. Peace Corps, Missionaries, and Other Citizens Residing Outside the United States. 
DO NOT COUNT
TB in persons diagnosed outside the United States should not be counted. TB in these 
persons should be counted by the country in which they are residing regardless of their 
plans to return to the United States for further work-up or treatment.
IV. Suggested Administrative Practices.—To promote uniformity in TB case counting,
the following administrative procedures are recommended:
(a) All TB cases verified during the calendar year by the 52 reporting areas with count 
authority (50 states, District of Columbia, and New York City) by December 31 will be 
included in the annual U.S. incidence count for that year. All tuberculosis cases 
verified during th.' calendar year by a reporting area with count authority from one of 
the remaining 7 reporting areas (American Samoa, Federated States of Micronesia, 
Guam, Northern Mariana Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin 
Islands) are also counted but are not included in the annual incidence for the United 
States. Cases for which bacteriologic results are pending or for which confirmation of
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disease is questionable for any other reason should not be counted until their status is 
clearly determined; they should be counted at the time they meet the criteria for 
counting. This means that a case reported in one calendar year could be included in the 
morbidity count for the following year. The reporting area with count authority should 
ensure that there is agreement between final local and state TB figures reported to CDC.
Currently, some reporting areas may not use this suggested protocol. Some of these 
areas may wait until the beginning of the following year when they have received and 
processed all of the TB cases for inclusion in the annual case count for the previous 
year. If reporting areas decide to revise their protocols, they should be aware that TB 
trends may change.
(b) TB is occasionally reported to health departments over the telephone, by letter or 
fax, or on forms other than the Report of Verified Case of Tuberculosis (RVCT). Such 
information should be accepted as an official morbidity report if sufficient details are 
provided; otherw ise, the notification should be used as an indicator of a possible TB 
case (suspect) wh*ch should be investigated promptly for confirmation.
V. TB Surveillance Definitions.
Case - an episode of TB disease in a person meeting the laboratory or clinical criteria 
for TB as defined in the document “Case Definitions for Infectious Conditions Under 
Public Health Surveillance”2 (see Section II for criteria).
Suspect - a person for whom there is a high index of suspicion for active TB (e.g., a 
known contact tc an active TB case or a person with signs/symptoms consistent with 
TB) who is currently under evaluation for TB disease.
Verification of a TB case - the process whereby a TB case, after the diagnostic 
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB 
control official who is familiar with TB surveillance definitions; if all the criteria for a 
TB case are met, *he TB case is then verified and eligible for counting.
Counting of a TB case - the process whereby a reporting area with count authority 
evaluates verified TB cases (e.g., assesses for case duplication). These cases are then 
counted for morbidity in that locality (e.g., state or county) and reported to CDC for 
national morbidity counting.
Mycobacterium tuberculosis complex (M. tuberculosis complex) * consists of three 
mycobacterial species: M. tuberculosis, M. bovis, and M. africanum. These species are 
identical in DNA homology studies. In terms of their ability to cause clinical disease 
and to be transmissible from person to person, M. bovis and M. africanum behave like 
M. tuberculosis; therefore, disease caused by any of the three organisms should be 
reported as TB, using the Report of Verified Case of Tuberculosis (RVCT). The only 
exception is the BCG strain of M. bovis, which may be isolated from persons who have 
received the vaccine to protect against TB or as cancer immunotherapy; disease caused
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by this M. bovis strain should not be reported as TB because the transmission is 
iatrogenic (treatment-induced), rather than person-to-person or communicable.
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium 
tuberculosis complex that can cause human infection or disease. Common 
nontuberculous mycobacteria include M. avium complex or MAC (M avium, M, 
intracellulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M, fortuitum, 
and M. simiae. Other terms have been used to represent NTM, including MOTT 
(mycobacteria other than TB) and “atypical” mycobacteria.
Reporting area - areas responsible for counting and reporting verified TB cases to 
CDC. Currently there are 59 reporting areas; 50 states, District of Columbia, New York 
City, American Samoa, Federated States of Micronesia, Guam, Northern Mariana 
Islands, Puerto Rico, Republic of Palau, and the U.S. Virgin Islands. Annual incidence 
of tuberculosis for the United States is based on 52 reporting areas (50 states, District of 
Columbia, and New York City).
Alien - defined by the Immigration and Naturalization Service (INS)4 as “any person 
not a citizen or national of the United States.”
Border crosser - defined, in part, by the Immigration and Naturalization Service (INS)4 
as “a nonresident alien entering the United States across the Mexican border for stays of 
no more than 72 hours.” Border crossers may go back and forth across the border many 
times in a short period.
Class A (TB, Infectious) - defined by the Division of Quarantine3 as an alien “with an 
abnormal chest radiograph or series of chest radiographs suggestive of current 
pulmonary TB and one or more positive sputum smear examinations for acid-fast 
bacilli.” This person is not authorized to enter the United States unless a waiver has 
been granted (see definition for Class A - TB, Infectious, “Noncommunicable for travel 
purposes.”)
Class A (TB, Infectious, “Noncommunicable for travel purposes”) - defined by the 
Division of Quarantine3 as an alien “with an abnormal chest radiograph or series of 
chest radiographs suggestive of active TB, a history of one or more positive sputum 
smear examinations for acid-fast bacilli, currently on recommended treatment, and 
sputum smears that are negative for acid-fast bacilli on 3 consecutive days.” This 
person is authorized to enter the United States if a waiver has been granted.
Class BI (TB, clinically active, not infectious) - defined by the Division of 
Quarantine3 as an alien “with an abnormal chest radiograph or series of chest 
radiographs suggestive of active TB, and sputum smears that are negative for acid-fast 
bacilli on 3 consecutive days.” This person may be on anti-TB medications when 
entering the United States.
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Class B1 (Extrapulmonary TB, clinically active, not infectious) - defined by the 
Division of Quarantine3 as an alien “with radiographic or other evidence of 
extrapulmonary TB, clinically active.” This person may be on anti-TB medications 
when entering the United States.
Class B2 (TB, not clinically active) - defined by the Division of Quarantine3 as an 
alien “with an abnormal chest radiograph or series of chest radiographs suggestive of 
active TB, not clinically active (e.g., fibrosis, scarring, pleural thickening, 
diaphragmatic tenting, blunting of costophrenic angles.) Sputum smears are not 
required.” Such a person who “completed the recommended course of anti-TB therapy 
and whose chest radiographs are stable should be reported as Class B2 - TB, treatment 
completed.” This person may be on anti-TB medications when entering the United 
States.
Class B3 (Consistent with TB, old or healed) - defined by the Division of Quarantine3 
as an alien “with an abnormal chest radiograph or series of chest radiographs (the only 
abnormality is a calcified lymph node, calcified primary complex, or calcified 
granuloma). Sputum smears are not required.”
Immigrant - defined by the Immigration and Naturalization Service (INS)4 as “an alien 
admitted to the United States as a lawful permanent resident. Immigrants are those 
persons lawfully accorded the privilege of residing permanently in the United States. 
They may be issued immigrant visas by the Department of State overseas or adjusted to 
permanent resident status by the Immigration and Naturalization Service of the United 
States.”
Permanent Resident Alien - see Immigrant.
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